ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP477	Cytoplasmic ribosomal proteins	76/3223	84/5488	8.87437110161989e-11	4.89865284809418e-08	4.89865284809418e-08	2197/9801/6134/4736/6135/6136/6137/23521/9045/6138/6139/6141/6142/6143/6144/6146/9349/6147/6152/6155/6157/6158/6159/6122/6156/6160/6161/6164/11224/6165/25873/6167/6168/6169/6170/6124/6171/6125/6128/6129/6130/6132/6133/6176/6181/6205/6206/6207/6208/6209/6217/6222/6223/6187/6224/6227/6228/6230/6231/6232/6233/6234/6235/6188/6189/6192/6193/6194/6196/27330/6198/6201/6202/6203/3921/7311	76
WP5218	Extrafollicular B cell activation by SARS-CoV-2	52/3223	62/5488	1.81088192057696e-05	0.00499803410079242	0.00499803410079242	57379/60468/604/613/29760/718/6366/1236/930/912/933/958/959/969/973/941/1378/1380/6387/7852/643/10148/2113/83416/2308/1880/29851/23308/3433/8519/3569/3662/3394/3687/3689/4094/4240/931/5079/5133/639/5788/6402/6776/6850/7099/51284/9168/7124/8741/10673/7494	52
WP69	T-cell receptor signaling pathway	65/3223	85/5488	0.000425332223143153	0.0782611290583402	0.0782611290583402	8915/84433/867/868/919/940/916/917/920/9308/925/1147/1385/28988/355/2353/2534/2625/2885/3265/29851/3551/8517/3601/3552/3553/3569/3662/3702/3708/3725/3932/10892/5604/5605/9020/6885/1326/11184/5599/4690/4772/4773/4790/4792/5295/5296/5335/5580/5588/9051/2185/5966/5970/8767/10019/6464/8631/7040/3604/7409/10451/7431/7454/7535	65
WP2849	Hematopoietic stem cell differentiation	34/3223	43/5488	0.00400343272593119	0.552032366188048	0.552032366188048	863/1435/1440/7852/2313/2353/2354/2624/55502/79366/10320/3552/3553/3569/3663/3690/4254/51176/4005/4066/4582/3071/4773/4851/399/8780/861/6688/6776/7068/7148/80342/23650/7409	34
WP2877	Vitamin D receptor pathway	89/3223	127/5488	0.00500029317199319	0.552032366188048	0.552032366188048	5243/215/11096/240/248/490/9914/604/151888/768/838/875/595/929/4345/958/928/997/1017/1030/1031/1032/634/23274/79789/1493/1565/29785/1576/1673/11221/1946/2308/1647/727936/3117/3118/3123/6927/3400/3486/9173/3662/3663/3394/3684/9365/9314/3827/3965/9926/56262/4084/4609/4650/4773/27035/5368/5467/639/5588/10125/6275/6277/6279/6280/6304/7869/6422/6517/10568/219855/6546/25928/6696/8027/79689/6819/6822/7040/7056/7078/7128/4982/8600/7292/7168/54210/113835	89
WP5072	Modulators of TCR signaling and T cell activation	44/3223	59/5488	0.0080513640692658	0.637653164929225	0.637653164929225	10425/8915/84433/868/919/940/916/917/921/925/1147/1606/10672/2885/3551/8517/3702/3932/10892/9020/1326/11184/4209/4790/4792/5295/5296/5335/5588/5777/5922/5966/5970/399/58490/10019/4068/6598/8651/7128/53347/7409/7535/677	44
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	42/3223	56/5488	0.00808618143931989	0.637653164929225	0.637653164929225	10598/8915/801/805/84433/867/940/920/959/925/11261/1147/1493/2353/2534/2885/29851/3551/8517/3702/3725/3932/10892/5604/5605/5609/9020/6885/1326/4690/4773/4790/4792/5133/5290/5335/5588/5777/5788/6237/7124/7535	42
WP268	Notch signaling	31/3223	40/5488	0.010097950855785	0.684642100529386	0.684642100529386	6868/51107/83464/1387/1487/1488/54567/1840/113878/196403/151636/23220/1855/1856/1857/3065/51763/182/3714/2648/3955/55534/4242/9612/23385/4851/4853/8650/5663/5664/5986	31
WP23	B cell receptor signaling pathway	67/3223	95/5488	0.0111626429434139	0.684642100529386	0.684642100529386	8915/604/640/29760/673/695/84433/867/930/933/973/974/975/1147/1380/1385/27071/2113/2308/2534/2549/2885/3059/3265/3551/8517/3635/3662/3725/7462/3932/10892/5604/5605/5608/6885/11184/5599/4208/4209/4609/4690/4773/4790/4792/118788/5294/5295/5296/8394/23396/5335/5336/5579/5580/26469/5777/5788/5880/2889/25780/5966/5970/6464/6850/7006/7409	67
WP2023	Cell differentiation - expanded index	11/3223	12/5488	0.0157928590813298	0.871166735588717	0.871166735588717	2146/10014/3398/9314/10637/4205/4208/4209/860/6722/6774	11
WP3617	Photodynamic therapy-induced NF-kB survival signaling	25/3223	32/5488	0.0173602066874563	0.871166735588717	0.871166735588717	597/329/330/595/959/1147/2920/112398/3551/3552/3553/3569/4312/4313/4314/4318/4790/4791/5966/5970/5971/7124/7132/7412/7422	25
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	15/3223	18/5488	0.0255373568757727	0.943940810295535	0.943940810295535	967/975/1956/2114/3315/3569/3791/4318/10611/5728/6647/8470/6696/6774/7099	15
WP4961	STING pathway in Kawasaki-like disease and COVID-19	15/3223	18/5488	0.0255373568757727	0.943940810295535	0.943940810295535	1147/2212/79792/3551/9641/8517/3553/3661/3708/4790/4792/4794/79671/5966/5970	15
WP262	Ebstein-Barr virus LMP1 signaling	17/3223	21/5488	0.0283199566729333	0.943940810295535	0.943940810295535	6364/6352/1147/3551/8517/3654/9020/4215/6885/5599/4790/4791/4792/5970/7124/8717/7185	17
WP4754	IL-18 signaling pathway	148/3223	228/5488	0.0300777764902625	0.943940810295535	0.943940810295535	59/11096/57679/55738/84364/467/567/572/9031/596/598/274/330/669/682/7832/836/26093/6364/6352/975/9308/1051/1071/1147/9076/24146/1364/1281/10063/1374/1499/58191/2920/2921/54205/1674/1938/2023/2035/8772/83541/355/356/55294/2335/2353/2896/3033/338442/8841/3068/3315/26353/8870/3551/84818/3606/10068/8809/8807/3553/3569/3654/81618/3725/4254/3831/10365/3932/83752/4050/5609/6885/8720/4205/56257/4312/4322/4313/4314/4318/4666/29781/653361/4790/4791/4792/4794/4843/27035/10062/3164/26012/142/51230/5295/5585/7941/5335/5337/5546/5579/5580/5728/5763/5778/5806/5834/8480/22821/5966/5970/5993/6004/6205/6198/57521/860/6257/8698/6385/80031/9497/6641/9021/6696/83931/3925/7052/7076/7078/7114/7124/7127/7128/4982/7132/8600/7157/7185/54822/83549/7422/51341/80149/55625/55311	148
WP453	Inflammatory response pathway	19/3223	24/5488	0.0301409459553966	0.943940810295535	0.943940810295535	940/958/959/941/942/1281/2335/3560/3561/3566/3911/3912/3915/3918/3932/7057/7059/7132/7535	19
WP1772	Apoptosis modulation and signaling	56/3223	81/5488	0.0341855094208958	0.943940810295535	0.943940810295535	9131/84883/317/572/9531/27113/596/597/598/638/329/330/640/90427/664/834/843/835/836/839/842/8738/54205/1616/2021/8772/355/356/2353/3303/27429/3551/7850/3654/3725/8567/9020/4217/5599/4790/4792/8682/5366/5587/5783/51651/8737/8797/8794/8793/7132/8718/8743/7157/8717/7187	56
WP3877	MYD88 distinct input-output pathway	14/3223	17/5488	0.0369572606020708	0.943940810295535	0.943940810295535	3552/3654/3725/4790/92610/7096/81793/7099/7100/10333/51284/51311/54106/7334	14
WP4846	SARS-CoV-2 and COVID-19 pathway	9/3223	10/5488	0.0390485886974804	0.943940810295535	0.943940810295535	38/59272/1514/8829/949/340024/51284/7113/56649	9
WP3945	TYROBP causal network in microglia	42/3223	60/5488	0.0475410242970164	0.943940810295535	0.943940810295535	55803/54518/51411/714/718/822/951/920/8832/58191/1806/2000/23307/79690/202309/26157/3059/3587/3597/3606/3684/3687/3689/284194/654346/4066/4094/3071/10577/375387/5341/170954/54502/5996/6039/864/64092/375035/10019/9056/6696/6776	42
WP1434	Osteopontin signaling	11/3223	13/5488	0.0479092403217143	0.943940810295535	0.943940810295535	1147/3551/3685/3690/5604/9020/4318/4790/5328/5970/6696	11
WP3958	GPR40 pathway	11/3223	13/5488	0.0479092403217143	0.943940810295535	0.943940810295535	2767/5310/5330/5331/5333/113026/51196/5335/5336/23007/5334	11
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	13/3223	16/5488	0.0529861428819328	0.943940810295535	0.943940810295535	19/2194/3156/3157/3949/51586/10062/5465/10891/6319/23411/51548/6721	13
WP75	Toll-like receptor signaling pathway	57/3223	84/5488	0.0532907752379622	0.943940810295535	0.943940810295535	208/6352/929/958/941/942/1147/4283/8772/2353/3551/9641/8517/3553/3569/3654/51135/3661/3663/3725/23643/5604/5605/5608/5609/6885/1326/5600/6300/5603/5599/4790/4792/5290/5293/5294/5295/5296/8503/23533/5970/8737/6696/6772/23118/257397/114609/7096/7098/7099/7100/10333/51284/51311/54106/7124/7187	57
WP4312	Rett syndrome causing genes	25/3223	34/5488	0.0541048813848152	0.943940810295535	0.943940810295535	673/1108/2775/3065/10014/3097/3064/3766/10765/4204/4208/9612/23314/6334/6595/6597/8243/23224/8831/9014/6907/79718/6925/8295/56949	25
WP5202	Alstrom syndrome	23/3223	31/5488	0.0554282633073621	0.943940810295535	0.943940810295535	7840/55330/26258/84984/55125/26052/84062/1874/23432/51668/26160/11020/28981/4645/55968/5727/11159/5989/5990/5991/23557/7029/80124	23
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	15/3223	19/5488	0.0556852763930683	0.943940810295535	0.943940810295535	472/596/598/1387/1786/1788/2033/2120/2322/2551/2553/3002/5728/6597/7014	15
WP384	Apoptosis modulation by HSP70	15/3223	19/5488	0.0556852763930683	0.943940810295535	0.943940810295535	9131/317/835/836/839/842/54205/8772/355/356/3303/4214/4790/8737/7132	15
WP4481	Resistin as a regulator of inflammation	21/3223	28/5488	0.0564386661481396	0.943940810295535	0.943940810295535	208/1147/3551/8517/3569/3708/4790/4792/5290/5293/5294/5330/5331/5332/5333/113026/51196/5335/5336/5970/7124	21
WP4329	miRNAs involvement in the immune response in sepsis	26/3223	36/5488	0.0672191790545004	0.943940810295535	0.943940810295535	1147/3002/3551/8517/3552/3569/3654/51135/3663/3934/6885/5599/114614/4790/4791/4792/5966/5970/5971/23118/7099/51284/51311/7124/7187/7412	26
WP5109	Familial hyperlipidemia type 2	10/3223	12/5488	0.0705296482728474	0.943940810295535	0.943940810295535	337/1071/2053/2690/3949/26119/4023/255738/5360/7391	10
WP3858	Toll-like receptor signaling related to MyD88	22/3223	30/5488	0.0720867261808576	0.943940810295535	0.943940810295535	1147/3551/9641/8517/3654/51135/3661/4790/4791/5966/5970/5971/114609/7096/7098/7099/7100/10333/51284/51311/54106/7187	22
WP4630	Measles virus infection	75/3223	114/5488	0.0723186292636017	0.943940810295535	0.943940810295535	317/572/27113/596/598/836/842/868/595/896/9134/30835/940/916/917/4179/1017/1021/1147/1459/54205/23586/9451/440275/8667/8772/355/356/2213/2353/3303/3305/3306/3551/9641/8517/3552/3553/3560/3561/3569/3654/51135/3661/3716/3718/3725/6885/5599/4478/4790/4791/4792/4938/5290/5293/5295/5296/8503/9367/5970/6504/6772/6774/6776/6777/23118/7099/51284/54106/7128/7157/8717/7187/7297	75
WP22	IL-9 signaling pathway	12/3223	15/5488	0.0751799798848186	0.943940810295535	0.943940810295535	2885/3561/3716/3718/5604/5605/5295/5296/6772/6774/6776/6777	12
WP3599	Transcription factor regulation in adipogenesis	14/3223	18/5488	0.0769269236441138	0.943940810295535	0.943940810295535	1051/1052/1385/2308/3569/3667/8660/23175/5599/5106/5468/10891/6517/7124	14
WP5194	Synthesis of ceramides and 1-deoxyceramides	14/3223	18/5488	0.0769269236441138	0.943940810295535	0.943940810295535	53947/84002/2683/64781/29956/79603/91012/253782/1674/8694/2531/166929/8877/7368	14
WP78	TCA cycle (aka Krebs or citric acid cycle)	14/3223	18/5488	0.0769269236441138	0.943940810295535	0.943940810295535	50/1738/2271/3418/3419/3421/4191/4967/6389/6390/6391/6392/8803/8802	14
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	29/3223	41/5488	0.0777669549724195	0.943940810295535	0.943940810295535	208/329/330/836/6352/1147/1499/8772/3065/3551/3569/3725/9020/6885/5599/4318/4790/4791/4792/5970/5971/8737/7124/51330/8742/7185/7186/7187/7188	29
WP481	Insulin signaling	97/3223	150/5488	0.077895387212491	0.943940810295535	0.943940810295535	208/10487/867/868/9265/1958/10938/30846/1978/5167/2319/2353/2308/2549/2885/2992/3265/3480/3551/3631/3636/3667/8660/3725/11127/5604/5605/5607/5608/5609/4214/4294/7786/9020/4215/4216/4217/9064/6885/1326/4293/11184/5871/8491/9448/11183/5600/6300/5603/5597/5599/50488/4641/5213/5288/5290/5293/5294/5295/5296/8503/5563/5579/5580/5583/5588/5590/5728/5770/5867/5880/2889/5967/57381/23433/6196/9252/27330/6198/10110/23678/6464/6513/6517/8773/8651/9021/10580/6722/6810/252983/9882/57761/7248/7249/6844/7494	97
WP4136	Fibrin complement receptor 3 signaling pathway	25/3223	35/5488	0.0852513383503173	0.943940810295535	0.943940810295535	868/929/1147/2921/3551/8517/3569/3654/51135/3661/3684/3689/23643/4790/4843/5290/5327/83593/5966/5970/6850/114609/7098/7099/7124	25
WP5095	Overview of proinflammatory and profibrotic mediators	39/3223	57/5488	0.0857280139730709	0.943940810295535	0.943940810295535	6356/6357/6359/6364/6366/6368/6369/6370/56477/6352/1435/1440/6387/10563/58191/2920/2921/6372/4283/10148/3606/3552/3553/11009/90865/3569/3574/4049/4312/4314/4318/4790/6696/7040/7124/8741/10673/7422/6375	39
WP3995	Prion disease pathway	23/3223	32/5488	0.0890860714111194	0.943940810295535	0.943940810295535	10538/53335/596/836/1106/1385/10664/1879/2033/2260/2534/7184/3309/3662/4208/4790/5079/2923/5452/5885/5993/6688/6774	23
WP2018	RANKL/RANK signaling pathway	37/3223	54/5488	0.090501319622122	0.943940810295535	0.943940810295535	208/867/1147/1513/2274/2353/3551/8517/3725/5604/5608/5609/6885/5599/4772/4790/4791/4792/9060/5295/5296/5335/5970/5971/6688/8878/6772/6850/23118/8792/4982/8600/7185/7186/7187/7188/7412	37
WP4816	TGF-beta receptor signaling in skeletal dysplasias	35/3223	51/5488	0.0955723547713861	0.943940810295535	0.943940810295535	81794/25805/1387/1499/2022/2033/2280/2353/3265/3624/3694/3716/3725/51176/10637/4052/4054/4790/860/864/6498/4088/4090/4091/4093/6696/6772/6774/7030/7040/7049/7050/7057/7124/23090	35
WP3851	TLR4 signaling and tolerance	19/3223	26/5488	0.0966284558489843	0.943940810295535	0.943940810295535	1147/3551/9641/8517/3569/3635/3654/51135/3661/6885/4790/4792/8737/23118/114609/7099/7124/7187/23471	19
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	19/3223	26/5488	0.0966284558489843	0.943940810295535	0.943940810295535	6352/941/942/1493/3560/3561/3566/51135/4790/4791/5133/10401/8651/6774/7040/7043/7099/51284/51311	19
WP49	IL-2 signaling pathway	28/3223	40/5488	0.0967057180843541	0.943940810295535	0.943940810295535	596/867/1154/2353/2534/2885/3265/3560/3561/3716/3718/3725/3932/5604/5605/4609/9111/5295/2185/6194/6198/6464/9021/6772/6774/6776/6777/6850	28
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	17/3223	23/5488	0.100090239998869	0.943940810295535	0.943940810295535	28976/1636/59272/617/3606/3569/54602/51103/91942/4790/79671/27035/51548/7014/54386/7124/7187	17
WP560	TGF-beta receptor signaling	33/3223	48/5488	0.100963208978167	0.943940810295535	0.943940810295535	25805/1387/1499/2022/2033/2280/2353/3265/3624/3694/3716/3725/51176/10637/4052/4790/860/864/6498/4088/4090/4091/4093/6696/6772/6774/7030/7040/7049/7050/7057/7124/23090	33
WP3937	Microglia pathogen phagocytosis pathway	26/3223	37/5488	0.101835440566686	0.943940810295535	0.943940810295535	712/713/714/1535/1536/2207/2209/3684/3689/653361/4689/3071/5290/5293/5294/5295/5296/8503/146850/5336/5777/5880/6850/54210/7409/10451	26
WP4271	Vitamin B12 disorders	9/3223	11/5488	0.10264678007652	0.943940810295535	0.943940810295535	81693/51293/166785/326625/25974/27249/4548/6947/6948	9
WP4919	Neuroinflammation	9/3223	11/5488	0.10264678007652	0.943940810295535	0.943940810295535	51008/1147/2353/3725/5599/4792/4843/5970/7099	9
WP734	Serotonin receptor 4/6/7 and NR3C signaling	13/3223	17/5488	0.105080010291484	0.943940810295535	0.943940810295535	466/673/1385/1958/2005/2778/3360/5604/5605/9261/5906/9252/6722	13
WP12	Osteoclast signaling	11/3223	14/5488	0.105433247610048	0.943940810295535	0.943940810295535	7965/9550/1513/3690/5599/5155/6548/6696/8792/4982/8600	11
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	11/3223	14/5488	0.105433247610048	0.943940810295535	0.943940810295535	3590/3569/3570/3716/3718/4790/5970/6659/6774/652995/6935	11
WP4582	Cancer immunotherapy by CTLA4 blockade	11/3223	14/5488	0.105433247610048	0.943940810295535	0.943940810295535	940/941/942/1493/3123/5290/5293/5295/5296/8503/5777	11
WP4830	GDNF/RET signaling axis	11/3223	14/5488	0.105433247610048	0.943940810295535	0.943940810295535	1499/2625/2674/26585/51668/11020/5979/6092/6299/9353/10252	11
WP5063	FOXP3 in COVID-19	11/3223	14/5488	0.105433247610048	0.943940810295535	0.943940810295535	940/941/942/50943/3560/3561/3569/3570/6774/6776/6777	11
WP5200	Dravet syndrome	11/3223	14/5488	0.105433247610048	0.943940810295535	0.943940810295535	801/805/5600/79109/4790/5290/55615/79899/253260/6328/6330	11
WP286	IL-3 signaling pathway	31/3223	45/5488	0.106697856748832	0.943940810295535	0.943940810295535	572/596/598/867/969/942/1439/5169/2353/2534/2885/3265/3563/3635/3716/3725/5604/5599/5293/5295/5296/5777/2889/6464/6774/6776/6777/6850/7040/7409/10971	31
WP4752	Base excision repair	22/3223	31/5488	0.112807413204958	0.943940810295535	0.943940810295535	27301/3146/3978/3980/8930/4350/4595/252969/55247/4913/4968/142/5423/5424/5425/57804/5426/5427/27343/23583/6996/7515	22
WP4149	White fat cell differentiation	20/3223	28/5488	0.118609557109282	0.943940810295535	0.943940810295535	1051/1052/1385/1495/1879/1959/2308/2624/2625/3661/3662/10365/9314/2122/10062/5468/6776/6777/7090/23090	20
WP4823	Genes controlling nephrogenesis	20/3223	28/5488	0.118609557109282	0.943940810295535	0.943940810295535	23607/1499/6387/7852/2118/2263/3207/8516/3791/4690/8440/4853/5155/5979/6092/6469/9353/6943/7422/54361	20
WP289	Myometrial relaxation and contraction pathways	76/3223	118/5488	0.120102418834837	0.943940810295535	0.943940810295535	59/71/109/111/113/115/133/466/467/1388/488/489/784/801/805/808/1264/1265/27297/1385/10488/2114/2353/2551/2553/2776/2778/2782/2783/10681/55970/54331/2788/2870/9446/2980/3486/3487/3553/3569/3708/3709/3725/23764/4790/4846/5142/5144/5569/5570/11142/5331/5333/5335/5336/5567/5573/5579/5580/5581/5583/5588/5590/5587/5996/6001/10636/6004/10287/5997/8490/8787/2810/6546/7531/10971	76
WP205	IL-7 signaling pathway	18/3223	25/5488	0.124558322514547	0.943940810295535	0.943940810295535	572/598/595/2534/3561/3574/3716/3718/5604/5605/4609/5295/5296/2185/6772/6774/6776/6777	18
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	18/3223	25/5488	0.124558322514547	0.943940810295535	0.943940810295535	163/1385/2561/2562/2564/2568/4804/4915/5290/5294/5295/5296/8503/5335/5728/6093/6464/6774	18
WP399	Wnt signaling pathway and pluripotency	50/3223	76/5488	0.126247805488106	0.943940810295535	0.943940810295535	8312/8313/595/896/1387/1454/1487/1488/1499/1500/1855/1856/1857/2033/10023/8321/7976/8323/8325/3725/3949/51176/4040/120892/6885/4316/4609/4800/51701/5328/5460/5467/5516/5523/28227/5527/5579/5580/5581/5583/5588/5590/5587/6932/7157/7482/54361/7474/81029/10009	50
WP5098	T-cell activation SARS-CoV-2	50/3223	76/5488	0.126247805488106	0.943940810295535	0.943940810295535	8915/598/84433/56477/595/919/940/916/917/920/941/942/1147/1493/2353/2534/2885/3123/3265/29851/3551/8517/8809/64207/3708/3725/3932/4049/10892/5604/5605/4772/4790/4792/5293/5295/5335/5533/5588/5728/10125/5970/253260/57521/7124/7157/7248/7249/7297/7535	50
WP4585	Cancer immunotherapy by PD-1 blockade	16/3223	22/5488	0.130551992448013	0.943940810295535	0.943940810295535	10538/916/917/925/3105/3123/3725/3932/10725/4772/4773/4790/5133/80380/6774/7535	16
WP3651	Pathways affected in adenoid cystic carcinoma	38/3223	57/5488	0.137784229809582	0.943940810295535	0.943940810295535	8289/51742/84159/472/546/54880/23774/1111/1387/1487/23220/2033/55294/2264/3265/221037/284058/7403/58508/9863/55534/5605/23269/4603/4609/26292/4781/4851/64324/5290/5728/29072/6595/8243/10847/9874/7157/29128	38
WP2328	Allograft rejection	46/3223	70/5488	0.141409660157736	0.943940810295535	0.943940810295535	5243/712/713/714/717/718/729/836/842/6366/940/958/959/941/942/1459/1493/6387/10563/4283/643/355/356/50943/2551/3002/3105/3111/3112/3115/3117/3118/3119/3123/3135/3552/3553/120892/5156/5551/5590/6772/7040/7124/7422/7431	46
WP3298	Melatonin metabolism and effects	21/3223	30/5488	0.14149756621132	0.943940810295535	0.943940810295535	348/406/801/805/1407/1408/1454/1557/1565/1889/1906/2308/3654/4128/4133/406938/4790/5187/8863/23411/6817	21
WP2916	Interactome of polycomb repressive complex 2 (PRC2) 	12/3223	16/5488	0.141761490893476	0.943940810295535	0.943940810295535	121536/8726/2145/2146/3720/23515/22823/5928/5931/23064/23512/9967	12
WP4478	LTF danger signal response pathway	12/3223	16/5488	0.141761490893476	0.943940810295535	0.943940810295535	177/929/3552/3553/3569/3654/51135/4057/4790/7099/7124/54210	12
WP4815	Glycosaminoglycan degradation	12/3223	16/5488	0.141761490893476	0.943940810295535	0.943940810295535	411/2799/2990/3073/3074/138050/60495/3373/8692/3423/3425/6448	12
WP5033	Genes associated with the development of rheumatoid arthritis	12/3223	16/5488	0.141761490893476	0.943940810295535	0.943940810295535	640/51744/958/1493/115352/3123/3663/3685/26147/26191/6583/7185	12
WP5094	Orexin receptor pathway	65/3223	101/5488	0.144923188855891	0.943940810295535	0.943940810295535	8553/655/1364/2920/51523/1628/9201/11056/1846/1958/1959/1960/2353/2354/2355/84662/1839/3309/3399/3400/3553/3569/3663/3720/9314/3908/3939/3949/4023/7798/23764/7873/4322/4314/4609/4846/3164/8013/8439/4976/23596/26031/5162/54704/5295/5296/5337/5468/5498/861/860/6498/6506/6513/6517/6696/6722/3371/7124/29896/7412/7422/7428/140612/9203	65
WP2855	Dopaminergic neurogenesis	10/3223	13/5488	0.145931008109957	0.943940810295535	0.943940810295535	216/1028/1644/4760/4929/5979/6469/6571/6774/7040	10
WP5174	Ulcerative colitis signaling	10/3223	13/5488	0.145931008109957	0.943940810295535	0.943940810295535	50943/2625/3561/3566/4094/4772/4790/64127/7040/7124	10
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	10/3223	13/5488	0.145931008109957	0.943940810295535	0.943940810295535	56624/64781/3480/4790/5290/5337/1901/1903/56848/7248	10
WP474	Endochondral ossification	36/3223	54/5488	0.146178103016483	0.943940810295535	0.943940810295535	9510/9507/11096/655/51719/801/805/1028/50515/1280/1515/5167/2260/2487/2690/3157/3480/3481/11127/4208/4322/4318/5327/5328/5727/860/864/85477/6660/55553/6696/6772/6777/7040/7078/7422	36
WP4808	Endochondral ossification with skeletal dysplasias	36/3223	54/5488	0.146178103016483	0.943940810295535	0.943940810295535	9510/9507/11096/655/51719/801/805/1028/50515/1280/1515/5167/2260/2487/2690/3157/3480/3481/11127/4208/4322/4318/5327/5328/5727/860/864/85477/6660/55553/6696/6772/6777/7040/7078/7422	36
WP5110	Familial hyperlipidemia type 3	8/3223	10/5488	0.147412785392466	0.943940810295535	0.943940810295535	337/348/1071/3949/4023/5360/949/7436	8
WP5205	Clock-controlled autophagy in bone metabolism	44/3223	67/5488	0.149782301442065	0.943940810295535	0.943940810295535	55626/393/406/83734/64422/84938/596/8553/79365/651/653/1407/1435/115908/1513/128338/1948/79443/3146/3569/3920/84557/81631/4772/4851/4862/9975/5187/9842/5563/860/10371/10507/5176/4090/4093/8878/7040/8792/4982/8600/10131/8408/7474	44
WP4008	NO/cGMP/PKG mediated neuroprotection	19/3223	27/5488	0.149891816093431	0.943940810295535	0.943940810295535	572/596/801/805/842/1385/54205/1742/2977/3553/4790/4792/4843/4846/5138/5139/5593/5970/7124	19
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	19/3223	27/5488	0.149891816093431	0.943940810295535	0.943940810295535	59272/1147/2729/2730/2977/3551/8517/3553/3569/3661/4312/4314/4790/4792/27035/5593/5970/7113/7124	19
WP1533	Vitamin B12 metabolism	24/3223	35/5488	0.155109365461126	0.943940810295535	0.943940810295535	19/348/875/6352/1491/3043/3553/3569/3949/84693/326625/4548/4790/4791/5327/5970/6288/6289/949/6647/6649/6947/6948/7124	24
WP2369	Histone modifications	24/3223	35/5488	0.155109365461126	0.943940810295535	0.943940810295535	121536/55870/8726/79813/10919/2145/2146/4297/9757/58508/8085/55904/64324/7799/6418/26040/9739/23067/29072/55209/9869/83852/64754/10322	24
WP3940	One-carbon metabolism and related pathways	24/3223	35/5488	0.155109365461126	0.943940810295535	0.943940810295535	10768/586/587/10390/55349/56994/51380/1491/1759/1788/55500/2729/2730/2878/2882/2936/4548/5130/5833/10400/5337/6470/6647/6649	24
WP4950	16p11.2 distal deletion syndrome	17/3223	24/5488	0.158824766790173	0.943940810295535	0.943940810295535	11273/718/930/975/1380/2885/8519/3791/4773/84901/5350/5867/79874/10806/25970/7185/7186	17
WP3624	Lung fibrosis	32/3223	48/5488	0.164946878198519	0.943940810295535	0.943940810295535	23250/655/6356/6352/1051/1215/1440/2920/1832/1906/255520/2006/26585/3553/3569/4204/4313/4318/4502/727897/5073/5155/5328/5806/5265/729238/6498/6696/7039/7040/7076/7124	32
WP4917	Proximal tubule transport	27/3223	40/5488	0.166239622968993	0.943940810295535	0.943940810295535	5243/358/476/481/245972/529/9550/51606/760/762/117247/6505/6575/6513/142680/6519/6520/55244/6522/8671/6523/160728/340024/54716/9056/23428/11136	27
WP5220	Metabolic reprogramming in pancreatic cancer	27/3223	40/5488	0.166239622968993	0.943940810295535	0.943940810295535	47/587/1738/2194/2673/2746/64841/2805/2821/3098/3099/3156/3158/3939/3949/5160/5162/8050/5238/22934/6566/9122/6513/8501/6646/7157/6675	27
WP4595	Urea cycle and associated pathways	15/3223	21/5488	0.16829942815126	0.943940810295535	0.943940810295535	435/445/2271/2746/2805/3945/4191/4843/4846/4942/5009/5831/8604/10165/10166	15
WP2853	Endoderm differentiation	70/3223	110/5488	0.169045064313358	0.943940810295535	0.943940810295535	31/121536/27245/10973/57198/655/2186/9044/708/9425/11190/23373/1488/1499/8450/1601/23576/23181/1844/1846/2005/8320/2131/2146/2308/2627/79977/3087/3198/3251/3720/3915/51176/10459/54799/22823/51701/4830/4851/26986/54623/79668/5087/5090/84295/23007/5460/23682/5916/64864/6001/6422/6478/154091/4088/83595/6671/6772/6875/6925/6932/7040/57690/27324/51366/10451/23286/7709/23528/58499	70
WP35	G protein signaling pathways	51/3223	79/5488	0.172564679522815	0.943940810295535	0.943940810295535	109/111/113/115/11216/11215/11214/9495/10270/9138/801/805/2767/2768/10672/9630/2771/2773/2774/2775/2776/2778/2782/2783/10681/55970/2788/2793/3265/3708/5136/5142/5144/5150/5151/8622/5331/5530/5533/5567/5573/5579/5580/5581/5583/5588/5590/5587/23683/6237/6548	51
WP536	Calcium regulation in cardiac cells	65/3223	102/5488	0.17554153772648	0.943940810295535	0.943940810295535	109/111/113/115/309/481/488/489/490/775/782/784/801/805/808/811/814/1131/1132/2280/2701/2707/10052/2767/2771/2773/2775/2776/2778/2782/2783/10681/55970/54331/2788/2870/3708/3709/5569/5570/11142/5331/5350/5567/5573/5579/5580/5581/5583/5588/5590/5587/5996/6001/10636/6004/10287/5997/8490/8787/2810/6546/57620/7531/10971	65
WP722	Serotonin HTR1 group and FOS pathway	20/3223	29/5488	0.175719732485471	0.943940810295535	0.943940810295535	673/1385/2005/2353/2771/2773/2775/3708/5604/5605/5608/4214/9261/7867/5290/5906/5923/10125/9252/6722	20
WP383	Striated muscle contraction pathway	13/3223	18/5488	0.178278035574648	0.943940810295535	0.943940810295535	59/71/1674/4604/4621/10398/7111/7134/7125/7168/7171/7273/7431	13
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	13/3223	18/5488	0.178278035574648	0.943940810295535	0.943940810295535	8706/8708/2683/8704/64781/2589/57452/2531/166929/81537/8877/56848/7368	13
WP4288	MTHFR deficiency	13/3223	18/5488	0.178278035574648	0.943940810295535	0.943940810295535	501/836/842/55349/56994/54205/1786/1788/79813/10919/55471/5130/10400	13
WP5130	Th17 cell differentiation pathway	38/3223	58/5488	0.178687322326747	0.943940810295535	0.943940810295535	406/919/916/917/920/1407/2353/50943/2625/3551/3553/50615/9466/3566/3569/3570/3662/3716/3725/3932/5599/4772/4790/4792/9572/5187/5335/5530/5588/6097/861/9021/6772/6774/6776/7040/7297/7535	38
WP2848	Pluripotent stem cell differentiation pathway	18/3223	26/5488	0.187400522512062	0.943940810295535	0.943940810295535	1435/1436/3577/3569/3570/3624/3815/4254/10637/4851/5155/6469/7040/7043/8600/7422/7482/7474	18
WP4545	Oxysterols derived from cholesterol	18/3223	26/5488	0.187400522512062	0.943940810295535	0.943940810295535	641371/55856/122970/11332/23597/1593/51302/1576/1628/1717/10682/2053/1880/80270/3638/7376/6097/6342	18
WP197	Cholesterol biosynthesis pathway	11/3223	15/5488	0.188629733854427	0.943940810295535	0.943940810295535	1717/2222/2224/3156/3157/3422/6307/4598/50814/6309/6713	11
WP4872	MAP3K1 role in promoting and blocking gonadal determination	11/3223	15/5488	0.188629733854427	0.943940810295535	0.943940810295535	8312/1499/2254/2263/10023/10912/4214/4216/5600/6093/54361	11
WP4970	Galanin receptor pathway	11/3223	15/5488	0.188629733854427	0.943940810295535	0.943940810295535	1028/1385/2353/3569/5468/10891/5580/6517/6844/7422/10413	11
WP5182	Pro-survival signaling of neuroprotectin D1	11/3223	15/5488	0.188629733854427	0.943940810295535	0.943940810295535	330/836/842/54205/8772/5516/8737/7124/7132/8717/7186	11
WP15	Selenium micronutrient network	36/3223	55/5488	0.189800193580153	0.943940810295535	0.943940810295535	19/240/847/875/1491/2678/2878/2936/3043/3553/3569/8564/8942/3949/4548/4790/4791/5327/55163/5052/7001/10935/10549/5970/55312/6288/6289/949/22928/6647/6649/7124/7295/10587/114112/7498	36
WP4658	Small cell lung cancer	58/3223	91/5488	0.192279514242719	0.943940810295535	0.943940810295535	208/317/596/598/329/330/836/842/595/9134/1017/1021/1028/1030/1147/1282/1284/1285/1286/1287/1288/54205/1870/2272/2335/1647/10912/3551/8517/3655/3685/3908/3910/3911/3912/3915/3918/10319/4609/4790/4792/4843/5290/5293/5295/5296/8503/5728/5915/5970/6257/6500/7157/7185/7186/7187/7188/7709	58
WP247	Small ligand GPCRs	9/3223	12/5488	0.198998175487537	0.943940810295535	0.943940810295535	1268/1269/5724/5729/5732/5733/1901/1903/8698	9
WP2513	Nanoparticle triggered regulated necrosis	9/3223	12/5488	0.198998175487537	0.943940810295535	0.943940810295535	8772/2512/5599/142/5321/8737/7124/7132/8717	9
WP3849	MAPK and NFkB signaling pathways inhibited by Yersinia YopJ	9/3223	12/5488	0.198998175487537	0.943940810295535	0.943940810295535	1147/3551/8517/5608/4214/9020/4790/4792/6237	9
WP4792	Purine metabolism	9/3223	12/5488	0.198998175487537	0.943940810295535	0.943940810295535	100/158/353/471/1716/3251/3614/5631/7498	9
WP5171	Leukotriene metabolic pathway	9/3223	12/5488	0.198998175487537	0.943940810295535	0.943940810295535	4363/240/4051/1666/1800/64174/2678/2687/22949	9
WP5198	Inflammatory bowel disease signaling	21/3223	31/5488	0.20174688752468	0.943940810295535	0.943940810295535	50943/2625/3606/8807/3552/50615/3561/3566/3569/3725/4094/4772/4790/64127/6097/6772/6774/7040/7099/7100/7124	21
WP395	IL-4 signaling pathway	34/3223	52/5488	0.201784448577669	0.943940810295535	0.943940810295535	572/867/1051/1147/2033/2353/2625/2885/3551/3561/3566/3635/3667/8660/3716/3718/5600/4790/4792/5290/5293/5295/5296/5777/5970/6198/6464/8651/9021/6772/6774/6776/6777/7297	34
WP585	Interferon type I signaling pathways	34/3223	52/5488	0.201784448577669	0.943940810295535	0.943940810295535	867/1385/1975/1978/2534/3667/8660/3716/3932/5608/4214/79109/27250/10401/5293/5295/5296/5777/5788/5906/2889/5966/6194/9252/6198/57521/8651/9021/6772/6774/6776/7297/7409/7535	34
WP2355	Corticotropin-releasing hormone signaling pathway	45/3223	70/5488	0.204440427214956	0.948328704392063	0.948328704392063	31/596/673/8912/836/842/1385/1499/1889/2353/2354/2355/2767/2771/2775/2776/2778/2782/2783/10681/2870/3606/3727/5604/4217/5599/4790/4792/4846/3164/4929/142/5335/5336/5563/5579/5580/5588/5908/5970/6822/6925/7040/7099/10155	45
WP4223	Ras signaling	91/3223	146/5488	0.20933387554015	0.962935827484689	0.962935827484689	208/572/598/801/805/808/91860/1147/1436/1956/1969/2113/2114/55770/356/2260/2263/2264/2321/2322/4303/2549/2782/2783/10681/55970/54331/2788/2793/2885/3265/3480/3551/8517/3791/3815/283455/5604/5605/5599/22808/4790/4804/4915/5156/5290/5293/5295/5296/8503/8399/5320/26279/5321/8398/51196/5335/5336/5337/5338/5567/5579/5869/5880/10928/5906/5908/5922/22821/10156/8437/9462/64926/5923/10125/10235/25780/115727/11186/83593/5966/5970/5863/9610/6237/6464/6789/8831/7010/7074/7535	91
WP2583	T cell receptor and co-stimulatory signaling	19/3223	28/5488	0.215932140615522	0.977004439506298	0.977004439506298	801/805/940/925/1493/1859/2534/3702/3932/4773/4790/4792/5133/5335/5530/5728/5777/10125/7535	19
WP4241	Type 2 papillary renal cell carcinoma	19/3223	28/5488	0.215932140615522	0.977004439506298	0.977004439506298	405/9915/1387/1513/1856/112398/2033/2271/5155/5546/29072/6513/7030/7942/7039/7040/7043/7422/7428	19
WP400	p38 MAPK signaling pathway	22/3223	33/5488	0.227741140218976	0.999496944584873	0.999496944584873	1385/1616/2885/3150/3265/3315/5608/4214/4217/6885/4293/9261/4209/4609/5321/5923/8737/9252/6464/6772/8717/7186	22
WP2374	Oncostatin M signaling pathway	41/3223	64/5488	0.229502122051308	0.999496944584873	0.999496944584873	836/1017/1051/1385/1958/2353/2885/3265/3667/3716/3718/3727/3949/3977/5604/5605/5599/4312/4322/4314/4790/4792/10401/5295/5579/5580/5581/5583/2185/5970/253260/6194/6464/9021/6772/6774/6777/7078/7157/7297/7422	41
WP3925	Amino acid metabolism	47/3223	74/5488	0.235967447025014	0.999496944584873	0.999496944584873	47/50/128/216/501/8639/384/445/586/875/1491/1644/1738/2184/10056/2271/2730/2744/2746/2752/2805/84706/2936/3033/3067/26275/3158/3417/3939/4128/92935/4191/4942/4953/4967/5009/8974/5160/8050/5166/151742/5831/6389/10993/8802/6898/6999	47
WP5087	Malignant pleural mesothelioma	216/3223	356/5488	0.23757582442596	0.999496944584873	0.999496944584873	59/71/72/9510/177/84962/208/154796/171023/467/472/8312/9532/8314/580/27113/596/648/685/834/6352/595/896/961/1009/28513/1001/1017/1022/57680/1282/1284/1285/1286/1287/1288/1385/1435/1436/1440/1454/1459/1487/1488/115908/1495/1499/6387/54205/1855/1856/1857/8726/1944/1946/1956/1975/1978/1981/1969/2146/2167/2254/2260/2263/2264/2321/2322/2335/2305/2308/10023/23401/8321/7976/8323/8325/2551/2885/1839/3054/3146/3150/3265/3480/3481/3553/3569/3672/3676/3655/3685/3689/3690/3716/3725/7403/3791/3815/4254/58508/3908/3910/3911/3912/3915/3918/10319/51176/3965/8994/4040/8379/4085/5604/5605/5607/5608/5609/4214/4294/4215/4216/4217/9064/4293/11184/5871/8491/9448/5599/9261/4192/4194/4209/50488/2872/4313/4314/4318/55233/92597/4485/4609/4771/4790/4804/4915/8473/5155/56034/80310/5156/1911/5281/5290/5293/5294/5328/5332/5420/64840/10891/5563/5564/51422/11098/5728/11186/9770/283349/83593/166824/5928/6015/6045/6194/9252/6198/57521/5176/29072/55209/9869/6422/6423/6464/6513/6520/6772/6788/23012/23512/6932/7003/7004/7010/7039/7040/23043/7157/7186/7248/7249/9675/29128/8408/7422/7423/7482/54361/7474/81029/23286/10413/7528	216
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	39/3223	61/5488	0.243387625677124	0.999496944584873	0.999496944584873	109/673/896/1017/1385/1958/2353/2768/10672/2771/2773/2775/2776/2778/2782/54331/3265/3480/3716/3725/5604/5608/4609/7849/5144/5290/5295/5296/5337/5906/5908/5934/6194/6198/23513/6772/6774/7270/8458	39
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	28/3223	43/5488	0.24404580661439	0.999496944584873	0.999496944584873	19/9619/39/2181/1593/1717/10682/9415/2194/2222/2224/3156/3157/3158/51478/3422/3930/6307/4598/29116/7376/10062/50814/6309/6319/6646/6713/6721	28
WP5097	CCL18 signaling pathway	20/3223	30/5488	0.244164065033774	0.999496944584873	0.999496944584873	59/205/467/2033/2335/3939/100506334/440823/4313/4318/4609/5728/2185/100505648/6513/6772/7004/652995/7412/7431	20
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	65/3223	104/5488	0.246671563182385	0.999496944584873	0.999496944584873	8553/836/55536/1051/1374/1385/1387/10664/1499/1644/10522/1889/1958/2033/2305/2597/2624/2625/3030/3032/3065/9734/7184/3329/3552/3553/3569/3570/3725/4128/4133/4150/4152/4204/4208/4760/4790/4791/4800/9722/4915/5087/5354/5452/5460/10891/133522/5567/5573/5978/5979/864/6330/6640/6751/6752/6929/7068/7124/11076/6844/7422/4904/7531/10971	65
WP3845	Canonical and non-canonical Notch signaling	15/3223	22/5488	0.249186790372504	0.999496944584873	0.999496944584873	1147/54567/23462/182/3714/51176/84441/55534/4236/4237/4851/4853/5663/5664/6237	15
WP430	Statin inhibition of cholesterol production	15/3223	22/5488	0.249186790372504	0.999496944584873	0.999496944584873	19/337/341/345/348/1071/8694/2222/3156/3949/4023/5360/949/6646/6713	15
WP4320	Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome	15/3223	22/5488	0.249186790372504	0.999496944584873	0.999496944584873	10951/23468/1107/1108/3065/51763/51176/8932/53615/9112/9219/57504/5928/5931/7157	15
WP4537	Hippo-Yap signaling pathway	15/3223	22/5488	0.249186790372504	0.999496944584873	0.999496944584873	11184/5871/8491/9448/50488/4485/4771/11186/6788/23012/7003/7004/23043/10971/55249	15
WP4018	Clear cell renal cell carcinoma pathways	51/3223	81/5488	0.253903540919233	0.999496944584873	0.999496944584873	31/47/230/405/8314/79365/80184/1387/1956/2023/2026/2027/5169/2033/2194/2321/2597/2821/3098/3099/3759/3791/3939/3945/197257/55193/5155/5156/5213/79605/5236/26227/29968/5728/57521/10993/29072/6470/6513/8878/8082/6774/7040/7043/84969/7167/7248/7249/7422/7428/6935	51
WP5055	Burn wound healing	57/3223	91/5488	0.25698923527472	0.999496944584873	0.999496944584873	8038/596/23476/836/916/1265/6387/3579/7852/2006/2162/2260/2263/2264/2335/60674/3146/3552/3553/3569/3624/3791/9314/23643/440823/4312/4322/4313/79148/4314/4318/4790/4792/64127/5216/6277/6280/8796/6423/4088/7040/7043/7076/7096/7098/7099/7100/10333/51284/51311/54106/3371/7124/7128/7157/7422/7431	57
WP117	GPCRs, other	18/3223	27/5488	0.262417935349326	0.999496944584873	0.999496944584873	140/9620/1951/1131/1268/3577/3579/1909/2149/29933/11245/2841/1880/9290/2918/59352/1901/6752	18
WP2533	Glycerophospholipid biosynthetic pathway	18/3223	27/5488	0.262417935349326	0.999496944584873	0.999496944584873	8760/10390/56994/2710/150763/2819/253430/23175/5833/10400/9489/55361/5290/5293/5294/8394/5320/9791	18
WP2806	Complement system	46/3223	73/5488	0.266153928018823	0.999496944584873	0.999496944584873	133/708/717/718/729/811/930/958/4179/966/22918/629/1675/3075/5199/1378/1380/2161/2162/2208/2214/2219/2286/2357/2771/2773/3384/3687/3689/3690/3911/3912/3915/5648/5329/5627/5806/6223/6402/710/729238/6696/7057/7295/11326/7454	46
WP3933	Kennedy pathway from sphingolipids	8/3223	11/5488	0.266788799568322	0.999496944584873	0.999496944584873	10390/56994/55500/5130/5833/10400/9791/81490	8
WP4211	Transcriptional cascade regulating adipogenesis	8/3223	11/5488	0.266788799568322	0.999496944584873	0.999496944584873	1051/1052/1054/1959/2624/2625/10365/5468	8
WP4495	IL-10 anti-inflammatory signaling pathway 	8/3223	11/5488	0.266788799568322	0.999496944584873	0.999496944584873	644/645/3587/3552/3569/3716/6772/6774	8
WP4504	Cysteine and methionine catabolism	8/3223	11/5488	0.266788799568322	0.999496944584873	0.999496944584873	875/51380/1491/23474/2729/2805/4548/6821	8
WP4629	Aerobic glycolysis	8/3223	11/5488	0.266788799568322	0.999496944584873	0.999496944584873	2023/2597/2821/3098/3939/5213/6513/7167	8
WP4788	Autosomal recessive osteopetrosis pathways	8/3223	11/5488	0.266788799568322	0.999496944584873	0.999496944584873	1186/3551/4790/28962/9842/29887/8792/8600	8
WP4842	Mammalian disorder of sexual development	8/3223	11/5488	0.266788799568322	0.999496944584873	0.999496944584873	1499/2254/2263/5600/5087/5730/30812/54361	8
WP382	MAPK signaling pathway	118/3223	193/5488	0.269023690743943	0.999496944584873	0.999496944584873	208/369/673/775/8912/9254/93589/782/783/784/836/929/994/1147/1616/11221/80824/1844/1845/1846/1956/2005/355/356/2254/2260/2263/2264/2317/2353/1647/2768/55970/2885/3265/3303/3305/3306/3315/3551/8517/3552/3553/7850/3725/3727/120892/5604/5605/5607/5608/5609/4214/7786/9020/4216/4217/9064/6885/1326/11184/5871/8491/9448/5600/6300/5603/5599/9479/23162/9261/7867/4208/2872/22808/4609/4772/4790/4791/51701/3164/4915/5155/5321/5494/5495/5530/5533/5534/5536/5567/5580/5778/5880/5906/5908/5922/5923/10125/10235/25780/115727/5970/5971/9252/6237/6722/6788/6789/3925/23118/57551/7040/7043/7124/7132/7157/7186	118
WP3613	Photodynamic therapy-induced unfolded protein response	16/3223	24/5488	0.282887031986397	0.999496944584873	0.999496944584873	467/27113/811/51726/4189/5611/9695/83939/9451/7184/3309/10130/23645/57761/7324/7494	16
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	16/3223	24/5488	0.282887031986397	0.999496944584873	0.999496944584873	1785/1959/121512/9896/54332/3315/26353/9516/90678/9927/5376/9230/5865/5867/53916/81846	16
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	33/3223	52/5488	0.291572577725389	0.999496944584873	0.999496944584873	843/1147/6387/1540/10521/1654/8653/23586/8772/3551/9641/8517/3661/4214/6885/5600/6300/5603/5599/4790/4792/79671/5970/8737/54941/80143/10010/9755/7124/8717/7186/7187/7706	33
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	11/3223	16/5488	0.291739868368519	0.999496944584873	0.999496944584873	7852/9595/182/51176/4851/5294/6932/3371/7412/7422/7428	11
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	11/3223	16/5488	0.291739868368519	0.999496944584873	0.999496944584873	919/916/917/920/925/2534/3123/3569/3932/55922/7535	11
WP530	Cytokines and inflammatory response	11/3223	16/5488	0.291739868368519	0.999496944584873	0.999496944584873	920/1435/1440/2920/3123/3552/3553/3569/3574/7040/7124	11
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	39/3223	62/5488	0.295967846206485	0.999496944584873	0.999496944584873	958/959/1673/2113/3265/10964/3551/3569/3716/3725/5600/6300/5603/5599/5469/4790/4791/64127/5330/5331/5332/5333/51196/5336/5579/5580/5581/5583/5588/5590/5971/91543/6257/6772/7099/51311/7124/7132/7297	39
WP4746	Thyroid hormones production and peripheral downstream signaling effects	45/3223	72/5488	0.29856489791782	0.999496944584873	0.999496944584873	109/364/572/842/10488/1499/50506/2260/2308/2885/3265/3685/3690/3709/51780/5604/11183/7867/11343/4851/7849/5290/5468/10891/5588/5593/6194/27330/6198/57521/9728/6469/51548/117247/6567/5172/9882/7068/7157/7248/7249/7270/8458/54361/9658	45
WP2857	Mesodermal commitment pathway	69/3223	112/5488	0.300097846819175	0.999496944584873	0.999496944584873	31/8728/121536/27245/84159/10973/57198/8312/8313/8553/655/708/203228/8030/55704/595/11190/23373/1466/1488/8450/23576/23181/2005/8320/2131/2132/2260/8325/2625/2627/79977/3251/3064/3624/3720/7403/9314/51176/10637/23499/54799/22823/51701/79668/5087/5090/84295/23007/5460/5573/5915/5916/6001/6169/29072/154091/4088/4091/6722/6925/7003/27324/10155/51366/10451/10413/23528/58499	69
WP231	TNF-alpha signaling pathway	57/3223	92/5488	0.300552808129886	0.999496944584873	0.999496944584873	317/572/598/329/330/836/842/11140/1147/1387/1535/8772/2752/2885/3265/3551/8517/3569/3725/283455/8567/5608/5609/4214/9020/4215/4217/6885/1326/5871/5599/4790/4791/4792/4794/27035/124056/8439/5590/5790/5836/5966/55312/8737/6500/6610/23118/257397/10010/7124/7128/7132/8717/7185/7186/10131/7295	57
WP129	Matrix metalloproteinases	14/3223	21/5488	0.306102858897143	0.999496944584873	0.999496944584873	682/4312/4319/4321/4322/4313/10893/79148/4314/4316/4318/7076/7078/7124	14
WP2865	IL1 and megakaryocytes in obesity	14/3223	21/5488	0.306102858897143	0.999496944584873	0.999496944584873	2149/2205/1839/3606/3553/3654/4318/4790/5290/7941/6280/8991/7076/7096	14
WP4532	Intraflagellar transport proteins binding to dynein	14/3223	21/5488	0.306102858897143	0.999496944584873	0.999496944584873	1781/51626/83658/6993/6990/51668/55764/9742/11020/112752/56912/57560/28981/57728	14
WP4726	Sphingolipid metabolism: integrated pathway	14/3223	21/5488	0.306102858897143	0.999496944584873	0.999496944584873	64781/29956/79603/91012/253782/123099/2531/166929/81537/6609/8877/56848/9517/7368	14
WP712	Estrogen signaling pathway	14/3223	21/5488	0.306102858897143	0.999496944584873	0.999496944584873	596/673/1147/1385/2353/2778/2782/2852/3551/8517/3725/5604/4790/5290	14
WP4971	Phosphoinositides metabolism	28/3223	44/5488	0.307523643518517	0.999496944584873	0.999496944584873	3635/8776/54545/8897/66036/5287/5288/5290/5293/5294/200576/5305/8396/8394/23396/5330/5331/5332/5333/113026/51196/5335/5336/23007/9651/5728/6305/81846	28
WP5038	Mitochondrial immune response to SARS-CoV-2	17/3223	26/5488	0.315206233340863	0.999496944584873	0.999496944584873	28976/1636/59272/617/1514/23586/9641/3661/51103/4790/4791/79671/27035/7098/51284/7113/7187	17
WP5090	Complement system in neuronal development and plasticity	52/3223	84/5488	0.315954629412949	0.999496944584873	0.999496944584873	317/23250/286410/5205/57198/558/712/713/714/717/718/729/733/10487/843/836/842/4179/966/629/1675/3075/5199/1191/81035/1378/1380/286204/1524/54205/355/356/2219/27429/3684/3685/3687/3689/3690/3993/2011/5648/4240/84612/5359/5590/5627/23513/710/7040/7043/7301	52
WP3591	Sleep regulation	9/3223	13/5488	0.318399302087093	0.999496944584873	0.999496944584873	100/2353/3606/3569/4862/8863/5729/5730/2030	9
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	9/3223	13/5488	0.318399302087093	0.999496944584873	0.999496944584873	19/348/1071/3949/26119/9388/4023/255738/949	9
WP5178	Disorders of fructose metabolism	9/3223	13/5488	0.318399302087093	0.999496944584873	0.999496944584873	216/132158/2821/3098/3795/5236/6523/6652/7167	9
WP2447	Amyotrophic lateral sclerosis (ALS)	20/3223	31/5488	0.321286205959399	0.999496944584873	0.999496944584873	57679/317/572/596/598/834/836/842/847/1616/5605/5608/4217/5530/5533/6506/6647/7124/7132/7157	20
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	20/3223	31/5488	0.321286205959399	0.999496944584873	0.999496944584873	904/1387/2033/3065/8841/10014/51564/9734/7469/25920/4772/4773/4790/4792/5530/5533/5534/5970/6827/6829	20
WP4756	Renin-angiotensin-aldosterone system (RAAS)	20/3223	31/5488	0.321286205959399	0.999496944584873	0.999496944584873	1636/466/1388/801/805/808/91860/57118/814/1215/1385/10488/90993/84699/9586/1511/2776/3708/3709/5330	20
WP4331	Neovascularisation processes	23/3223	36/5488	0.32546020298764	0.999496944584873	0.999496944584873	94/6387/7852/54567/2048/182/3791/3815/4254/5599/4318/4790/4791/4851/5155/5966/5970/5971/4088/4090/4093/7040/7043	23
WP4673	Male infertility	56/3223	91/5488	0.331227505782876	0.999496944584873	0.999496944584873	5243/3983/57491/406/472/596/847/904/905/8476/1106/1191/1387/30827/56603/2033/2067/2068/355/356/2346/2775/3981/222229/4057/27030/4313/4318/4522/4548/4843/4846/142/10400/143689/5395/5423/5428/5445/55170/29968/23369/9985/5981/8787/6470/55423/113235/6649/6660/6948/7057/7124/9319/83983/7517	56
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	32/3223	51/5488	0.331678865579273	0.999496944584873	0.999496944584873	6868/64919/4345/1499/1523/1956/1959/2353/2354/8321/2619/2625/23560/55806/3725/4254/51176/26018/4772/4790/4851/4853/8842/864/6275/6422/25928/11005/6929/6925/7040/7474	32
WP4655	Cytosolic DNA-sensing pathway	35/3223	56/5488	0.332518997546767	0.999496944584873	0.999496944584873	9447/834/843/6352/1147/1540/23586/8772/3551/9641/8517/3606/3553/90865/3569/3661/4790/4792/79671/9533/51082/55703/661/55718/10621/10622/84265/171568/51728/5970/8737/54941/8717/11277/7706	35
WP5193	Cholesterol synthesis disorders	12/3223	18/5488	0.332835061865475	0.999496944584873	0.999496944584873	1717/10682/2222/2224/3156/3157/3422/3930/6307/4598/6309/6713	12
WP299	Nuclear receptors in lipid metabolism and toxicity	15/3223	23/5488	0.341076668841733	0.999496944584873	0.999496944584873	19/5243/5244/8714/225/5825/9619/1576/10062/9971/5465/5467/5468/5915/5916	15
WP143	Fatty acid beta-oxidation	18/3223	28/5488	0.346092365870172	0.999496944584873	0.999496944584873	37/38/2181/51703/55902/1374/1666/1738/1892/2639/2710/2820/3033/3030/3032/4023/788/7167	18
WP455	GPCRs, class A rhodopsin-like	54/3223	88/5488	0.347687036614956	0.999496944584873	0.999496944584873	1238/51554/136/140/150/1233/1236/10803/1131/1132/1268/1269/1524/3577/3579/7852/643/10800/1909/1910/2149/9002/2867/2357/2358/2852/23432/84636/2841/9283/2863/8477/8843/3360/57121/1241/10316/4886/5540/23596/27334/9934/5031/5724/5729/11251/5732/5733/23637/266747/6751/6752/56670/2829	54
WP2333	Trans-sulfuration pathway	7/3223	10/5488	0.350752899091265	0.999496944584873	0.999496944584873	875/51380/1491/1786/2730/2805/4548	7
WP2879	Farnesoid X receptor pathway	7/3223	10/5488	0.350752899091265	0.999496944584873	0.999496944584873	5244/1576/2289/8660/9971/10891/6822	7
WP3930	EDA signaling in hair follicle development	7/3223	10/5488	0.350752899091265	0.999496944584873	0.999496944584873	649/1896/4050/5727/5971/6469/25928	7
WP5050	TCA cycle in senescence	7/3223	10/5488	0.350752899091265	0.999496944584873	0.999496944584873	673/2271/2805/4200/5160/57546/7157	7
WP5108	Familial  hyperlipidemia type 1	7/3223	10/5488	0.350752899091265	0.999496944584873	0.999496944584873	337/1071/3949/64788/4023/5360/6400	7
WP5118	SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome	7/3223	10/5488	0.350752899091265	0.999496944584873	0.999496944584873	472/9656/22976/56852/5885/10111/8243	7
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	7/3223	10/5488	0.350752899091265	0.999496944584873	0.999496944584873	23586/3661/3140/7098/51284/51311/8792	7
WP5188	Retinol metabolism	7/3223	10/5488	0.350752899091265	0.999496944584873	0.999496944584873	216/1551/317749/10170/8228/112724/195814	7
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	10/3223	15/5488	0.36426676037034	0.999496944584873	0.999496944584873	595/5167/56975/2263/2591/9365/4790/4791/142680/6696	10
WP254	Apoptosis	49/3223	80/5488	0.366513131072417	0.999496944584873	0.999496944584873	317/572/27113/596/598/329/330/834/843/835/836/839/842/1147/8738/54205/8772/355/356/3002/3480/3481/3551/8517/3661/3662/3663/3725/4049/4214/4609/4790/4792/4794/5295/5366/5551/5970/8737/7124/7132/27242/8718/8743/7157/8717/7185/7186/7187	49
WP2507	Nanomaterial induced apoptosis	13/3223	20/5488	0.370725942308193	0.999496944584873	0.999496944584873	9131/317/596/836/839/842/54205/2021/8772/355/356/27429/5551	13
WP4725	Sphingolipid metabolism overview	13/3223	20/5488	0.370725942308193	0.999496944584873	0.999496944584873	64781/29956/79603/253782/123099/2531/166929/81537/6609/8877/56848/9517/7368	13
WP5064	7-oxo-C and 7-beta-HC pathways	13/3223	20/5488	0.370725942308193	0.999496944584873	0.999496944584873	641371/55856/122970/11332/23597/1593/1628/1717/10682/2053/3290/10577/6342	13
WP2880	Glucocorticoid receptor pathway	37/3223	60/5488	0.372255376812029	0.999496944584873	0.999496944584873	11214/347902/221079/84002/8553/329/330/6364/10602/1028/29103/8507/121512/9982/387509/3725/3895/56262/4240/4791/5142/10769/5460/81706/5997/6286/6337/6397/5272/9792/1836/10252/2040/7049/7056/7128/1831	37
WP4313	Ferroptosis	37/3223	60/5488	0.372255376812029	0.999496944584873	0.999496944584873	2181/51703/84883/1645/1646/8644/246/875/51510/55847/27235/1491/1536/1803/2222/2512/2729/2730/3156/3315/10162/84557/81631/8031/27035/5261/5447/112483/4891/81539/64116/6520/30061/55240/7037/7157/7419	37
WP61	Notch signaling pathway	34/3223	55/5488	0.373475638542911	0.999496944584873	0.999496944584873	6868/51107/83464/595/54567/1840/2033/55294/2625/3065/55502/23462/182/3714/3932/84441/55534/4609/9612/23385/4790/4851/4853/8650/5295/5296/5663/5664/6015/8819/6500/23013/6774/7088	34
WP558	Complement and coagulation cascades	28/3223	45/5488	0.375396669717731	0.999496944584873	0.999496944584873	712/713/714/717/718/729/733/4179/629/1675/3075/1191/1378/1380/2161/2149/3827/3998/5648/5327/5328/5329/5627/5265/5104/5345/710/7056	28
WP4172	PI3K-Akt signaling pathway	155/3223	259/5488	0.379654536898441	0.999496944584873	0.999496944584873	208/1388/572/596/598/842/595/896/9134/930/11140/1017/1021/1147/1280/1282/1284/1285/1286/1287/1288/1293/1298/1385/10488/90993/84699/9586/1435/1436/1440/1441/54541/1944/1946/1956/1975/9470/1978/1969/2149/356/2254/2260/2263/2264/2321/2322/2335/92579/2690/2782/2783/10681/55970/54331/2788/2793/2885/3265/3326/7184/3480/3481/3551/8517/3560/3561/3563/3566/3569/3570/3574/3667/3672/3676/3655/3679/8516/3680/3685/3690/3694/3716/3718/3791/3815/4254/3908/3910/3911/3912/3915/3918/10319/9170/57121/5604/5605/4609/4790/4804/4846/4915/5106/5155/56034/80310/5156/23035/118788/5290/5293/5294/5295/5296/8503/23533/146850/5585/5586/29941/5516/5523/28227/5526/5527/5528/5563/5728/5934/5970/6194/6198/57521/10110/23678/6696/6794/6850/8115/7010/7039/7057/7058/7059/117145/7099/3371/7148/7157/7248/7249/7422/7423	155
WP3646	Hepatitis C and hepatocellular carcinoma	29/3223	47/5488	0.397938998102478	0.999496944584873	0.999496944584873	598/330/836/842/595/1284/3577/1870/356/2487/2885/6927/3569/3570/3716/3725/51176/5599/4312/4609/26509/4790/4843/5420/4088/6774/7040/7157/7422	29
WP364	IL6 signaling pathway	26/3223	42/5488	0.399962509929661	0.999496944584873	0.999496944584873	572/598/1387/2549/2885/3065/3569/3570/3716/5604/5605/6885/51701/5295/5296/639/5580/6198/6464/9021/6772/6774/7076/7297/7409/7432	26
WP3878	ATM signaling in development and disease 	26/3223	42/5488	0.399962509929661	0.999496944584873	0.999496944584873	472/545/9212/1020/8851/80254/1111/64421/3150/3315/8517/3930/4217/9656/4790/8493/5536/10111/5923/165918/9025/8243/6794/7158/10155/7249	26
WP1602	Nicotine effect on dopaminergic neurons	8/3223	12/5488	0.40237004772989	0.999496944584873	0.999496944584873	1020/1136/1138/1644/2782/54331/5499/6571	8
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	8/3223	12/5488	0.40237004772989	0.999496944584873	0.999496944584873	1385/3685/3690/3725/8076/5335/5588/7134	8
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	8/3223	12/5488	0.40237004772989	0.999496944584873	0.999496944584873	38/39/2222/2224/3156/3157/3422/4598	8
WP5173	Disorders of galactose metabolism 	8/3223	12/5488	0.40237004772989	0.999496944584873	0.999496944584873	231/2584/2592/2992/8908/5236/5836/6523	8
WP465	Tryptophan metabolism	20/3223	32/5488	0.403578559435623	0.999496944584873	0.999496944584873	51166/38/216/8854/217/26/847/1573/1576/1644/1892/2639/23498/3033/3028/11185/8942/4129/4967/6999	20
WP4298	Acute viral myocarditis	45/3223	74/5488	0.404821469567094	0.999496944584873	0.999496944584873	596/598/663/79886/834/835/836/839/842/595/920/959/941/54108/1385/1525/7852/54205/1906/1981/2021/2534/3569/3683/3689/3716/51528/3908/4318/4791/64127/26986/142/5295/5880/6443/6444/8651/6772/6774/7040/7098/7099/7100/7124	45
WP24	Peptide GPCRs	17/3223	27/5488	0.404946339926474	0.999496944584873	0.999496944584873	10396/1233/1236/10803/1524/3577/3579/7852/643/1909/1910/2357/2358/4886/5540/6751/6752	17
WP1584	Type II diabetes mellitus	11/3223	17/5488	0.405301712424001	0.999496944584873	0.999496944584873	2710/3551/3667/5599/23533/5580/5590/6517/122809/6834/7124	11
WP391	Mitochondrial gene expression	11/3223	17/5488	0.405301712424001	0.999496944584873	0.999496944584873	814/1385/2551/2553/3054/50804/4899/10891/133522/5530/23082	11
WP357	Fatty acid biosynthesis	14/3223	22/5488	0.405705978815262	0.999496944584873	0.999496944584873	10449/31/47/2181/51703/55902/1666/55862/55268/1892/2194/3033/51102/6319	14
WP4482	Vitamin D in inflammatory diseases	14/3223	22/5488	0.405705978815262	0.999496944584873	0.999496944584873	1147/3551/8517/3569/5608/4214/4772/4790/4792/5530/5534/5970/4088/7124	14
WP4969	RAS and bradykinin pathways in COVID-19	14/3223	22/5488	0.405705978815262	0.999496944584873	0.999496944584873	1636/59272/1576/2161/3552/3553/3816/3827/4790/4846/5592/6093/710/7124	14
WP5092	Interactions of natural killer cells in pancreatic cancer	14/3223	22/5488	0.405705978815262	0.999496944584873	0.999496944584873	6868/648/6352/2214/2308/2624/3002/4277/4609/259197/374383/5551/201633/7124	14
WP710	DNA damage response (only ATM dependent)	58/3223	96/5488	0.409561153757266	0.999496944584873	0.999496944584873	208/472/8312/572/27113/596/604/638/847/595/896/901/1499/1855/1856/1857/356/10023/2885/3146/3265/3667/3725/3949/51176/4214/4216/6885/5599/4609/4790/4791/5106/5287/5288/5290/5293/5294/5295/5296/8503/23533/5328/5366/5527/5728/5880/5934/6342/6464/4088/6932/7040/7157/7482/54361/7474/81029	58
WP3929	Chemokine signaling pathway	84/3223	140/5488	0.413717887758747	0.999496944584873	0.999496944584873	109/111/113/115/208/673/6356/6359/6364/6366/6369/6370/56477/6352/1233/1236/10803/1147/1445/1524/6387/10563/58191/2921/4283/3579/7852/643/1794/9844/2771/2773/2782/2783/10681/55970/54331/2788/2793/2885/2870/3265/3551/8517/3702/3718/5604/653361/4790/4792/5290/5293/5294/5295/5296/8503/23533/5330/5331/5332/57580/5567/5579/5580/5590/5613/2185/5880/5906/5908/10235/5970/6093/6464/6772/6774/6777/7074/26230/7409/10451/7454/6375/2829	84
WP5180	DYRK1A	33/3223	54/5488	0.416596713710137	0.999496944584873	0.999496944584873	51107/23621/836/842/595/1021/1385/1408/1759/1859/1874/1875/8893/2308/91750/132660/23385/4772/4851/5663/23132/5928/5934/5978/57521/23411/6598/10253/7027/7029/7157/7248/7249	33
WP4540	Hippo signaling regulation pathways	49/3223	81/5488	0.418739617080309	0.999496944584873	0.999496944584873	1009/28513/1001/1436/1499/1956/1969/2260/2263/2264/2321/2322/2767/2771/2773/2774/2776/2778/3480/3791/3815/51176/4485/4771/4804/4915/5156/5330/5331/5332/5563/5564/5567/51422/5573/5579/5580/5581/5583/5588/5590/23683/4088/6788/6932/7003/7004/7010/55249	49
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	27/3223	44/5488	0.423137146218305	0.999496944584873	0.999496944584873	695/6356/1154/1978/2534/3569/3716/3932/5604/5605/5599/4609/4790/4791/4792/55361/5290/5970/5971/6194/6772/6774/6776/6777/7006/7292/7525	27
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	40/3223	66/5488	0.429042116983613	0.999496944584873	0.999496944584873	467/8312/8313/595/896/1021/57680/1454/1459/1487/1488/1499/1855/1856/1857/2146/10023/23401/8321/7976/8323/8325/3725/51176/4040/6885/4609/51701/5328/64840/8607/5176/6422/6423/6929/6932/7482/54361/7474/81029	40
WP4666	Hepatitis B infection	79/3223	132/5488	0.432408711140091	0.999496944584873	0.999496944584873	208/317/369/1388/572/596/673/843/836/842/1147/1385/10488/90993/84699/9586/1387/54205/1654/23586/1959/1960/2033/8772/355/356/2353/2885/3265/3339/3551/9641/8517/3569/3654/51135/3661/3716/3718/3725/5604/5605/5608/5609/4214/6885/5600/6300/5603/5599/4318/4609/4772/4773/4790/5290/5293/5295/5296/8503/5579/2185/5970/4088/6772/6774/6776/6777/23118/7040/7043/114609/7098/7099/7124/7187/7297/7419/10971	79
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	37/3223	61/5488	0.432804362034659	0.999496944584873	0.999496944584873	8312/595/896/57680/1454/1459/1487/1488/1499/57291/1855/1856/1857/2146/10023/23401/8321/7976/8323/8325/3725/9314/51176/4040/4609/51701/5328/64840/5176/6422/6423/83595/6932/7482/54361/7474/81029	37
WP3972	PDGFR-beta pathway	18/3223	29/5488	0.434057792827983	0.999496944584873	0.999496944584873	2353/2885/3265/3716/3725/5604/4214/5599/5290/5295/5335/5579/6464/6722/6772/6774/6776/6777	18
WP304	Kit receptor signaling pathway	34/3223	56/5488	0.436772265536953	0.999496944584873	0.999496944584873	572/596/695/867/1796/2033/2353/2534/2885/3265/3635/3815/4254/5604/5605/5599/4145/5295/5296/5335/5579/5777/6194/6198/6464/8651/9306/6772/6774/6776/6777/6909/7006/7409	34
WP4150	Wnt signaling in kidney disease	15/3223	24/5488	0.43805939693396	0.999496944584873	0.999496944584873	1499/1855/1856/1857/8321/7976/8323/8325/27130/4040/5599/7482/54361/7474/81029	15
WP581	EPO receptor signaling	15/3223	24/5488	0.43805939693396	0.999496944584873	0.999496944584873	1154/2885/3667/8660/5604/5605/5294/5788/10076/6464/8651/6772/6774/6776/6777	15
WP3645	NAD+ biosynthetic pathways	12/3223	19/5488	0.442256108318641	0.999496944584873	0.999496944584873	683/952/55191/142/143/23411/23410/23408/51548/51547/6999/80351	12
WP2895	Differentiation of white and brown adipocyte	9/3223	14/5488	0.446602308996343	0.999496944584873	0.999496944584873	655/1051/1054/5468/10891/133522/4090/4093/23090	9
WP4538	Regulatory circuits of the STAT3 signaling pathway	41/3223	68/5488	0.447140551525392	0.999496944584873	0.999496944584873	1387/1438/1439/1441/1844/1956/2149/9002/2690/3460/3587/3590/3601/53832/50615/9466/3560/3561/3563/3570/3716/3718/3977/5600/6300/5603/5597/5599/79109/5156/10401/5579/5788/5789/253260/57521/9021/6774/3925/10155/7297	41
WP2332	Interleukin-11 signaling pathway	25/3223	41/5488	0.45032168362635	0.999496944584873	0.999496944584873	466/596/1147/1385/2534/2885/3265/3551/3590/3716/5604/5605/10401/5295/5296/5970/6194/6198/860/9021/6772/6774/7040/7297/7525	25
WP314	Fas ligand pathway and stress induction of heat shock proteins	25/3223	41/5488	0.45032168362635	0.999496944584873	0.999496944584873	71/317/397/596/843/836/839/842/54205/1616/8772/355/356/3315/3552/3725/4214/6885/5599/9261/7867/4799/142/8767/7124	25
WP428	Wnt signaling	51/3223	85/5488	0.451170115030515	0.999496944584873	0.999496944584873	8312/595/896/57680/1454/1459/1487/1488/1499/23002/1855/1856/1857/10023/23401/8321/7976/8323/8325/2239/27130/3725/51176/4040/6885/5599/4609/4772/4773/51701/5328/5330/5331/5332/64840/5530/5533/5534/144165/166336/5579/5176/6422/6423/6932/81839/57216/7482/54361/7474/81029	51
WP2261	Glioblastoma signaling pathways	48/3223	80/5488	0.455470874798616	0.999496944584873	0.999496944584873	208/369/472/673/867/595/1017/1021/1030/1031/1956/2033/2260/2263/2308/4303/2549/2885/3265/3480/3667/5604/5605/5607/5608/5609/4194/2956/5156/5287/5288/5290/5293/5294/5295/5296/5335/5336/5579/5580/5583/5588/5590/5728/10253/7157/7248/7249	48
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	35/3223	58/5488	0.456367858347308	0.999496944584873	0.999496944584873	59272/682/6352/11126/6387/10563/2920/2921/6372/4283/3579/23586/2033/8772/3433/8519/3569/3570/3661/3716/3902/4790/8480/8737/4088/6772/10010/7040/51284/7124/8717/7186/7187/7188/7706	35
WP3981	miRNA regulation of prostate cancer signaling pathways	19/3223	31/5488	0.461445186271433	0.999496944584873	0.999496944584873	572/596/842/595/90993/1387/1499/2308/2885/8517/5604/5605/84901/4790/4792/5290/23228/6932/7157	19
WP2795	Cardiac hypertrophic response	32/3223	53/5488	0.461471520406849	0.999496944584873	0.999496944584873	208/801/805/1022/1147/2263/10014/51564/9734/3551/9641/8517/5604/5605/5607/5608/5609/4214/9020/6885/11184/5599/4205/4773/4790/5320/5530/5587/5592/7040/7124/7132	32
WP2112	IL-17 signaling pathway	16/3223	26/5488	0.468047038507877	0.999496944584873	0.999496944584873	1051/1052/3551/8517/23765/55540/84818/3716/9020/6885/4790/5290/5970/6774/7187/10758	16
WP5102	Familial partial lipodystrophy (FPLD)	16/3223	26/5488	0.468047038507877	0.999496944584873	0.999496944584873	208/8815/63924/2167/2624/2625/23463/10365/687/4023/11343/5290/5465/5468/5396/6777	16
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	39/3223	65/5488	0.469911636028348	0.999496944584873	0.999496944584873	31/47/1385/1622/2194/2222/2224/3156/3157/3422/3638/3949/23175/4023/8720/51586/4800/7376/5290/5468/133522/5563/5564/51422/5950/11236/51128/22937/949/6319/6396/10484/10802/9871/22872/23411/6713/6721/7528	39
WP1541	Energy metabolism	26/3223	43/5488	0.473022529957793	0.999496944584873	0.999496944584873	814/1385/2033/2308/2551/3065/5469/4205/4208/4209/4899/5465/5467/5468/10891/133522/5530/5533/5534/23082/5563/5564/51422/23411/23410/7351	26
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	36/3223	60/5488	0.47538053896717	0.999496944584873	0.999496944584873	977/23607/941/1028/9076/1285/1286/1287/1378/1499/1514/1759/2534/3685/3690/182/3911/3987/4040/4627/4690/4851/55742/5329/51196/5335/5420/5800/950/11346/7040/7099/7225/7414/7431/10971	36
WP4686	Leucine, isoleucine and valine metabolism	13/3223	21/5488	0.475738452851148	0.999496944584873	0.999496944584873	27034/38/197322/4329/586/587/1738/1892/26275/3028/3712/64087/5096	13
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	13/3223	21/5488	0.475738452851148	0.999496944584873	0.999496944584873	317/572/27113/596/598/836/842/8772/356/5600/6300/5603/7124	13
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	13/3223	21/5488	0.475738452851148	0.999496944584873	0.999496944584873	115/1385/2776/2778/3708/5330/5331/5332/6490/5567/5579/5176/7422	13
WP3915	Angiopoietin-like protein 8 regulatory pathway	73/3223	123/5488	0.482537309684353	0.999496944584873	0.999496944584873	208/10487/867/868/1576/1978/23265/2194/2319/2308/3265/3667/8660/4023/5604/5605/5607/5608/5609/4214/4294/7786/9020/4215/4216/4217/9064/6885/1326/4293/11184/5871/8491/9448/11183/5600/6300/5603/5597/5599/79109/50488/10062/5288/5290/5293/5294/5295/5296/8503/5563/5564/51422/5770/2889/23433/253260/6196/9252/27330/6198/57521/6319/143686/6464/6567/6513/6517/6721/7068/9322/7248/7249	73
WP4493	Cells and molecules involved in local acute inflammatory response 	10/3223	16/5488	0.485144913706706	0.999496944584873	0.999496944584873	718/729/3552/3569/3676/3683/3689/3827/7124/7412	10
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	10/3223	16/5488	0.485144913706706	0.999496944584873	0.999496944584873	2005/2776/3265/3708/5604/5605/9261/5923/10125/6722	10
WP619	Type II interferon signaling	20/3223	33/5488	0.487226054306787	0.999496944584873	0.999496944584873	4283/1536/2633/2537/3433/3460/3553/3662/3394/3716/4843/4938/5580/5698/5967/8651/9021/6688/6772/6890	20
WP3676	BDNF-TrkB signaling	17/3223	28/5488	0.495902481649852	0.999496944584873	0.999496944584873	673/1385/1742/29904/1978/2549/2885/3265/5604/4915/5294/5335/6198/6464/7225/7248/7249	17
WP186	Homologous recombination	7/3223	11/5488	0.497690073256416	0.999496944584873	0.999496944584873	472/5424/5425/57804/10111/5893/6117	7
WP3971	OSX and miRNAs in tooth development	7/3223	11/5488	0.497690073256416	0.999496944584873	0.999496944584873	655/1499/6927/9314/4851/4853/860	7
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	7/3223	11/5488	0.497690073256416	0.999496944584873	0.999496944584873	604/54880/8726/2146/84678/6045/23512	7
WP554	ACE inhibitor pathway	7/3223	11/5488	0.497690073256416	0.999496944584873	0.999496944584873	1636/59272/1215/1511/3827/4846/7040	7
WP4674	Head and neck squamous cell carcinoma	41/3223	69/5488	0.505000356288458	0.999496944584873	0.999496944584873	84962/208/329/595/1021/1499/8452/54541/1956/1978/8772/2260/2263/2280/2549/3265/3480/79109/4790/4791/4851/4853/8650/5290/5294/5295/5296/23533/5563/5728/5966/5970/253260/6194/57521/6794/7157/7187/7248/7249/7422	41
WP4900	Purinergic signaling	14/3223	23/5488	0.506240460996305	0.999496944584873	0.999496944584873	136/140/2771/2773/2775/2778/5023/5025/5026/5027/27334/9934/5031/286530	14
WP531	DNA mismatch repair	14/3223	23/5488	0.506240460996305	0.999496944584873	0.999496944584873	9156/3978/2956/5395/5424/5425/57804/5426/5427/5981/5983/5984/6117/6118	14
WP2516	ATM signaling pathway	21/3223	35/5488	0.511512556175188	0.999496944584873	0.999496944584873	472/835/995/1017/1111/8738/1385/2177/1647/8517/3725/9656/4194/4792/10111/5883/8737/8243/9874/7157/7158	21
WP524	G13 signaling pathway	21/3223	35/5488	0.511512556175188	0.999496944584873	0.999496944584873	397/9138/801/805/10672/10788/3984/4216/5216/5290/5293/5296/5305/5585/85415/6093/6198/6242/57630/10188/7454	21
WP2324	AGE/RAGE pathway	38/3223	64/5488	0.511663988011945	0.999496944584873	0.999496944584873	177/836/842/1147/54205/1956/2308/4303/3551/51135/3667/3725/5604/5599/4322/4313/4316/4318/4478/653361/4790/4792/4843/4846/5321/5579/5580/5590/5970/6093/6464/4088/6647/6772/6774/6776/6777/114609	38
WP1544	MicroRNAs in cardiomyocyte hypertrophy	45/3223	76/5488	0.515128323913896	0.999496944584873	0.999496944584873	208/801/805/1022/1147/1154/1499/1855/1906/8893/2263/8321/10014/51564/9734/3480/3551/9641/8517/4040/5604/5605/5607/5608/5609/9020/5599/50804/4790/5290/5293/5294/5295/5296/8503/5320/5330/5530/5579/5592/6093/6774/7040/7124/7474	45
WP3893	Development and heterogeneity of the ILC family	11/3223	18/5488	0.519177877587399	0.999496944584873	0.999496944584873	64919/8320/2625/6927/3398/3606/3553/90865/3569/3574/7124	11
WP4722	Glycerolipids and glycerophospholipids	11/3223	18/5488	0.519177877587399	0.999496944584873	0.999496944584873	56895/1040/56994/8694/55500/5130/5833/10400/5337/9791/81490	11
WP5044	Kynurenine pathway and links to cell senescence	11/3223	18/5488	0.519177877587399	0.999496944584873	0.999496944584873	51166/440275/2308/23498/7850/8564/8942/6999/7099/7124/7157	11
WP545	Complement activation	11/3223	18/5488	0.519177877587399	0.999496944584873	0.999496944584873	712/713/714/717/718/729/733/629/1675/5199/5648	11
WP2371	Parkinson's disease pathway	18/3223	30/5488	0.521832539401293	0.999496944584873	0.999496944584873	317/835/836/839/842/9134/54205/1644/27429/120892/5600/6300/5603/23208/7326/7327/118424/9246	18
WP4496	Signal transduction through IL1R	18/3223	30/5488	0.521832539401293	0.999496944584873	0.999496944584873	1147/3551/3552/3553/3569/3654/3725/5608/4214/9020/6885/5599/4790/4792/5970/7040/7043/7124	18
WP4656	Joubert syndrome	39/3223	66/5488	0.528945385759631	0.999496944584873	0.999496944584873	54806/203286/200894/403/472/27077/80776/585/27241/22897/80184/95681/79598/1069/1855/1857/56623/27130/9786/4644/4646/284086/51199/8481/142/5116/5145/5147/10464/117177/10111/6469/51684/79600/79867/51524/51259/9094/23090	39
WP2858	Ectoderm differentiation	60/3223	102/5488	0.534807308544518	0.999496944584873	0.999496944584873	54806/55843/54828/54880/10486/440193/50937/1487/1499/1896/2263/2274/2300/2534/8325/10634/2627/3148/4061/4204/4609/7593/4771/4772/51701/4926/8473/9924/5150/5236/23133/5297/5362/5420/5452/5467/8495/51422/5783/5787/6238/5269/6469/6498/57154/8835/10253/7903/8675/6907/6929/4982/27324/51592/7226/8848/25987/7343/54521/57621	60
WP3644	NAD+ metabolism	8/3223	13/5488	0.536723240758367	0.999496944584873	0.999496944584873	952/65220/142/23411/23410/23408/51548/51547	8
WP3853	ERK pathway in Huntington's disease	8/3223	13/5488	0.536723240758367	0.999496944584873	0.999496944584873	836/1385/1956/3265/3064/5609/4915/9252	8
WP4584	Biomarkers for pyrimidine metabolism disorders	8/3223	13/5488	0.536723240758367	0.999496944584873	0.999496944584873	1152/1723/1806/80324/6240/50484/7084/1890	8
WP4760	PKC-gamma calcium signaling pathway in ataxia	8/3223	13/5488	0.536723240758367	0.999496944584873	0.999496944584873	2767/9630/2776/2893/3708/5330/5331/5332	8
WP5111	Familial hyperlipidemia type 4	8/3223	13/5488	0.536723240758367	0.999496944584873	0.999496944584873	337/1071/355/3949/64788/4023/5360/6400	8
WP4222	Phosphodiesterases in neuronal function	19/3223	32/5488	0.546019487031462	0.999496944584873	0.999496944584873	109/111/113/115/1385/2977/10846/5136/5138/5139/5140/5142/5144/5145/5147/5150/5151/8622/5152	19
WP4542	Leukocyte-intrinsic Hippo pathway functions	19/3223	32/5488	0.546019487031462	0.999496944584873	0.999496944584873	1236/930/83706/2308/4303/50943/3683/4023/55233/4485/639/5906/83593/6788/23012/7003/7004/10413/10971	19
WP2037	Prolactin signaling pathway	44/3223	75/5488	0.553866094147045	0.999496944584873	0.999496944584873	116986/836/867/1154/1978/2353/2534/2885/3265/3667/8660/3716/3725/5604/5605/5599/4609/4752/4790/4792/4843/10401/5290/5294/5295/5296/5479/5770/5777/5970/6194/6196/6198/6464/8651/8835/9021/6772/6774/6776/6777/7006/7409/7535	44
WP4016	DNA IR-damage and cellular response via ATR	44/3223	75/5488	0.553866094147045	0.999496944584873	0.999496944584873	472/545/580/604/79184/995/1017/22897/1111/1196/63967/9521/9156/2177/55215/2305/8924/3364/8517/4171/79648/9656/142/5423/8493/5810/5884/10111/5893/5883/5965/9400/55159/6117/6118/6601/8243/55775/11073/7157/7158/10155/51720/5976	44
WP2431	Spinal cord injury	51/3223	87/5488	0.554193002351359	0.999496944584873	0.999496944584873	358/7832/713/836/595/900/961/1017/50515/1280/1282/1464/2920/1875/1948/1956/1958/2043/2212/2280/2353/1647/3552/3553/3569/10288/4050/1241/4282/4321/4318/4609/4804/4843/3164/9423/5320/8398/5362/5530/57142/9353/7040/7099/7124/8741/10673/7157/1462/7431/64131	51
WP3959	DNA IR-double strand breaks and cellular response via ATM	30/3223	51/5488	0.554426943858048	0.999496944584873	0.999496944584873	317/472/545/641/836/842/995/1020/1111/64421/9156/2177/3297/79648/9656/142/5884/10111/5893/5883/11186/9025/8243/6788/7014/7157/7158/10155/5976/10413	30
WP98	Prostaglandin synthesis and regulation	23/3223	39/5488	0.556015998591952	0.999496944584873	0.999496944584873	231/1645/1646/8644/306/307/309/873/1906/1909/1910/27306/3290/5321/5468/10891/133522/5729/5730/5732/5733/6281/6277	23
WP2636	Common pathways underlying drug addiction	16/3223	27/5488	0.559829872808097	0.999496944584873	0.999496944584873	71/72/369/801/805/814/1385/2778/2893/5604/5605/5499/5567/5579/5906/5908	16
WP2839	Hair follicle development: organogenesis - part 2 of 3	16/3223	27/5488	0.559829872808097	0.999496944584873	0.999496944584873	595/1499/1896/2263/8321/23560/3624/3911/51176/4609/4790/5156/5727/860/6469/7474	16
WP408	Oxidative stress response	16/3223	27/5488	0.559829872808097	0.999496944584873	0.999496944584873	847/1536/2353/2729/2878/2936/4128/4257/4501/4784/4790/27035/6647/6649/10587/7498	16
WP176	Folate metabolism	27/3223	46/5488	0.564764564432166	0.999496944584873	0.999496944584873	19/847/875/1435/1491/2878/3043/3553/3569/3949/4522/4548/4790/4791/5327/5970/55312/6288/6289/949/6470/6573/113235/6647/6649/7124/7157	27
WP500	Glycogen synthesis and degradation	20/3223	34/5488	0.5686238182042	0.999496944584873	0.999496944584873	801/805/808/2992/8908/3098/3099/80201/5236/5255/5261/5516/5523/28227/5526/5527/5528/5834/5836/7360	20
WP1946	Cori cycle	9/3223	15/5488	0.570105631935348	0.999496944584873	0.999496944584873	2597/2821/3098/3939/5223/6513/6517/6888/7167	9
WP3927	BMP signaling in eyelid development	9/3223	15/5488	0.570105631935348	0.999496944584873	0.999496944584873	1956/2263/3725/4214/4851/6422/6469/4090/7039	9
WP4462	Platelet-mediated interactions with vascular and circulating cells	9/3223	15/5488	0.570105631935348	0.999496944584873	0.999496944584873	6352/958/959/3553/7040/7043/7099/51284/7412	9
WP497	Urea cycle and metabolism of amino groups	9/3223	15/5488	0.570105631935348	0.999496944584873	0.999496944584873	384/435/445/1152/2746/4942/4953/5009/5831	9
WP5074	Kallmann syndrome	9/3223	15/5488	0.570105631935348	0.999496944584873	0.999496944584873	55636/2260/2885/5605/5290/5588/60675/9723/26022	9
WP516	Hypertrophy model	9/3223	15/5488	0.570105631935348	0.999496944584873	0.999496944584873	467/1978/1839/3606/3552/3727/8013/7422/6935	9
WP4290	Metabolic reprogramming in colon cancer	24/3223	41/5488	0.576421024930556	0.999496944584873	0.999496944584873	47/50/2023/2194/2271/2597/2744/2746/2821/3418/3419/3939/4191/10606/5160/5162/5223/5226/29968/5831/22934/6390/6513/6888	24
WP26	S1P receptor signal transduction	13/3223	22/5488	0.576896470902983	0.999496944584873	0.999496944584873	208/2771/2773/6300/5597/5287/5330/5331/1901/1903/6610/8877/56848	13
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	13/3223	22/5488	0.576896470902983	0.999496944584873	0.999496944584873	9914/598/595/1051/1147/1956/4609/5770/8792/8600/23508/7392/7528	13
WP2911	miRNA targets in ECM and membrane receptors	13/3223	22/5488	0.576896470902983	0.999496944584873	0.999496944584873	1281/1282/1284/1290/1293/2335/3672/3694/3910/3915/7057/7058/7148	13
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	13/3223	22/5488	0.576896470902983	0.999496944584873	0.999496944584873	2805/3553/3569/4191/142/5970/9997/23411/23410/23408/6513/6517/7157	13
WP3286	Copper homeostasis	28/3223	48/5488	0.583490978895437	0.999496944584873	0.999496944584873	6868/8754/540/23621/836/595/150684/10063/2308/3725/4493/4495/4501/4502/4520/22823/5290/5728/6341/9997/4891/1317/1318/6647/6649/55240/79689/7157	28
WP4758	Nephrotic syndrome	21/3223	36/5488	0.589786998742122	0.999496944584873	0.999496944584873	54443/8542/83478/977/23607/1285/1286/1287/27235/1493/2013/4627/57107/51196/5373/5420/5800/950/11346/7225/84942	21
WP2034	Leptin signaling pathway	43/3223	74/5488	0.592550589794715	0.999496944584873	0.999496944584873	31/572/598/595/1147/1154/1385/1978/2308/2534/2885/3265/3551/8517/3553/3667/3716/5604/5605/5599/4790/4846/5140/5295/5296/5335/5336/5563/5728/5770/5966/5970/6093/6194/6198/25970/6464/8835/9021/30837/6772/6774/6777	43
WP1971	Integrated cancer pathway	25/3223	43/5488	0.595708128178892	0.999496944584873	0.999496944584873	466/472/545/572/580/27113/596/641/836/842/994/1017/1030/1111/3716/4217/4312/2956/4609/5451/5728/10111/4088/6772/7157	25
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	10/3223	17/5488	0.599206629824857	0.999496944584873	0.999496944584873	1385/3685/3690/3708/3725/8076/5335/5588/7082/7414	10
WP4784	Proteoglycan biosynthesis	10/3223	17/5488	0.599206629824857	0.999496944584873	0.999496944584873	126792/26229/124583/113189/2131/2132/9060/1836/64131/64132	10
WP1991	SRF and miRs in smooth muscle differentiation and proliferation	6/3223	10/5488	0.600961739649766	0.999496944584873	0.999496944584873	9314/4205/4208/4209/93649/6722	6
WP2436	Dopamine metabolism	6/3223	10/5488	0.600961739649766	0.999496944584873	0.999496944584873	1644/4128/4129/5516/5567/6647	6
WP3630	NAD metabolism, sirtuins and aging	6/3223	10/5488	0.600961739649766	0.999496944584873	0.999496944584873	2308/4790/142/5468/23411/23410	6
WP5176	Disorders of bile acid synthesis and biliary transport	6/3223	10/5488	0.600961739649766	0.999496944584873	0.999496944584873	5244/5205/1593/3295/80270/6342	6
WP4906	3q29 copy number variation syndrome	29/3223	50/5488	0.601311277173814	0.999496944584873	0.999496944584873	84984/51626/83658/6993/6990/55294/3077/3725/9587/4609/23077/4771/375387/5130/8503/11158/165918/9025/205564/23411/30061/6776/6777/7037/7040/7334/26043/348793/7629	29
WP5083	Neuroinflammation and glutamatergic signaling	58/3223	100/5488	0.60139953718282	0.999496944584873	0.999496944584873	109/596/801/805/814/1385/1610/1738/2353/2744/2752/2805/2893/2899/2918/3460/3587/3597/3552/3553/7850/3566/3569/3570/3667/3716/56262/55144/4049/4790/4791/26012/5160/26227/5330/5331/5332/5499/5579/29968/6470/6505/6506/6513/81539/92745/6536/4088/9021/6772/6774/7040/7043/7049/7124/7132/7188/54795	58
WP1539	Angiogenesis	14/3223	24/5488	0.601693950683588	0.999496944584873	0.999496944584873	405/1387/2263/2321/3791/4318/4846/5155/5156/5290/5335/7010/7078/7422	14
WP2197	Endothelin pathways	14/3223	24/5488	0.601693950683588	0.999496944584873	0.999496944584873	488/10203/801/805/1264/1889/1906/1909/1910/2778/10681/5604/4846/4886	14
WP4521	Glycosylation and related congenital defects	14/3223	24/5488	0.601693950683588	0.999496944584873	0.999496944584873	79868/199857/10195/79053/79796/2683/22845/1798/84061/4247/9526/4351/5373/7991	14
WP5114	Nucleotide excision repair in xeroderma pigmentosum 	33/3223	57/5488	0.606632409980174	0.999496944584873	0.999496944584873	902/1022/1069/9557/8450/2067/2068/2071/2072/2966/728340/3150/3978/3980/142/5424/5425/57804/5426/5427/5429/56852/5981/5983/5984/6117/6118/84464/128710/7874/57654/56949/7515	33
WP5088	Prostaglandin signaling	15/3223	26/5488	0.624318185935497	0.999496944584873	0.999496944584873	834/940/1435/4283/3552/3553/3569/3824/4318/4790/5294/5732/7040/7124/7422	15
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	11/3223	19/5488	0.624945310331941	0.999496944584873	0.999496944584873	31/8452/3939/5160/5162/5564/6194/4891/6513/7157/7422	11
WP4874	CAMKK2 pathway	19/3223	33/5488	0.625810574300665	0.999496944584873	0.999496944584873	8874/801/805/814/1131/1385/2033/28964/4094/84557/4773/5970/57521/23411/8243/8878/6786/7248/7412	19
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	19/3223	33/5488	0.625810574300665	0.999496944584873	0.999496944584873	1147/23586/2353/3551/9641/8517/3661/3716/3725/6885/5599/4790/4792/4938/8737/6772/51284/7187/7297	19
WP3941	Oxidative damage response	23/3223	40/5488	0.628275534549797	0.999496944584873	0.999496944584873	317/572/596/712/713/714/717/836/842/1028/1380/54205/1647/4214/4293/5603/4790/4794/7124/10188/7185/7186/7187	23
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	7/3223	12/5488	0.631138108993552	0.999496944584873	0.999496944584873	595/1364/3655/4609/6422/7040/7124	7
WP4891	COVID-19 adverse outcome pathway	7/3223	12/5488	0.631138108993552	0.999496944584873	0.999496944584873	59272/1440/3553/3569/3574/7113/7124	7
WP3611	Photodynamic therapy-induced AP-1 survival signaling	27/3223	47/5488	0.631227682173654	0.999496944584873	0.999496944584873	596/598/602/90427/595/1956/355/356/2353/1839/3569/3725/5608/5609/4217/5600/6300/5603/5599/4313/5156/7124/7132/8743/7157/7186/7188	27
WP4565	Neural crest cell migration in cancer	20/3223	35/5488	0.644772167576215	0.999496944584873	0.999496944584873	208/1009/2048/2051/2353/3725/4313/4318/4804/4915/5290/5293/5294/8503/23533/146850/6272/6774/7074/7204	20
WP3529	Zinc homeostasis	16/3223	28/5488	0.645066394352424	0.999496944584873	0.999496944584873	4493/4495/4501/4502/4520/7779/55532/7782/10463/57181/91252/29985/55630/283375/25800/64116	16
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	16/3223	28/5488	0.645066394352424	0.999496944584873	0.999496944584873	9509/649/90993/8321/3708/4040/8720/5033/8974/5034/5351/5479/5176/8792/4982/8600	16
WP2637	Interleukin-1 (IL-1) structural pathway	28/3223	49/5488	0.647594551869042	0.999496944584873	0.999496944584873	1147/2353/3551/3552/3654/51135/5604/5605/5608/5609/4214/9020/4215/6885/1326/5600/5599/9261/2872/4609/4790/4792/5970/9252/6294/23118/257397/10010	28
WP3584	MECP2 and associated Rett syndrome	28/3223	49/5488	0.647594551869042	0.999496944584873	0.999496944584873	26084/604/50937/1052/1267/1385/1465/10664/2146/2289/2893/3065/3187/3480/3481/4204/4208/4354/9315/11168/5728/5978/6194/25942/6872/6890/23435/4904	28
WP51	Regulation of actin cytoskeleton	66/3223	115/5488	0.653323045375663	0.999496944584873	0.999496944584873	71/9138/9459/8874/10458/673/55845/929/1131/1132/1445/26999/1793/1956/55740/2149/2245/2254/2260/2263/2264/2335/28964/2768/10672/55970/2934/3672/3984/5604/5605/5597/22808/4478/4628/10787/5155/5156/5216/5287/5288/5290/5293/5294/5295/5296/8503/23533/5305/8396/8394/23396/4659/5880/5962/6093/6237/6548/54434/85464/54961/7114/7409/7414/7429/7454	66
WP3935	Leptin-insulin signaling overlap	8/3223	14/5488	0.656884483107731	0.999496944584873	0.999496944584873	3667/8660/5294/8503/8651/8835/9021/6774	8
WP5061	Fatty acid transporters	8/3223	14/5488	0.656884483107731	0.999496944584873	0.999496944584873	2181/51703/1622/2169/2170/2167/2172/10999	8
WP5101	Congenital generalized lipodystrophy (CGL)	8/3223	14/5488	0.656884483107731	0.999496944584873	0.999496944584873	208/8694/2534/2885/3667/23175/64900/5290	8
WP53	ID signaling pathway	8/3223	14/5488	0.656884483107731	0.999496944584873	0.999496944584873	1017/2004/2005/3398/3399/5079/7849/5934	8
WP2884	NRF2 pathway	63/3223	110/5488	0.661048722626001	0.999496944584873	0.999496944584873	8714/10057/177/218/645/873/874/8824/283848/3337/1958/1969/2512/2729/2730/2678/2878/2936/2941/2948/2950/1839/3326/3303/23764/4258/5155/5226/5467/5052/9588/22949/5265/6513/66035/154091/114134/6517/6518/11182/56606/57181/91252/29985/55630/283375/25800/64116/6523/115584/6526/8884/160728/11254/340024/54716/6536/6649/8878/7039/7040/7295/114112	63
WP127	IL-5 signaling pathway	21/3223	37/5488	0.662469384196102	0.999496944584873	0.999496944584873	596/695/1439/2353/2885/3716/3725/5604/5605/4609/5294/5295/5296/6194/6198/6464/6772/6774/6776/6777/6850	21
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	17/3223	30/5488	0.664178504200228	0.999496944584873	0.999496944584873	572/1978/2308/4303/3265/4846/5290/5294/5295/5296/8503/5728/253260/57521/7942/7249/8408	17
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	17/3223	30/5488	0.664178504200228	0.999496944584873	0.999496944584873	208/3265/5604/5605/4318/4790/5290/5293/5294/5330/5331/5332/5579/5580/5581/5583/5588	17
WP4922	Mitochondrial complex IV assembly	17/3223	30/5488	0.664178504200228	0.999496944584873	0.999496944584873	1352/84987/51241/10063/90639/9377/1337/1340/1347/1349/1350/25994/25953/9997/6834/51204/80775	17
WP1528	Physiological and pathological hypertrophy of the heart	13/3223	23/5488	0.668749283781664	0.999496944584873	0.999496944584873	801/805/1906/2353/3725/3977/5600/5599/50804/5530/5579/5581/6774	13
WP4197	Immune response to tuberculosis	13/3223	23/5488	0.668749283781664	0.999496944584873	0.999496944584873	3430/3434/3437/8519/3460/3716/4938/5696/5771/8651/6772/6890/7297	13
WP195	IL-1 signaling pathway	30/3223	53/5488	0.677838405061069	0.999496944584873	0.999496944584873	1147/3551/8517/3552/3553/3654/51135/3725/5604/5605/5608/5609/4214/9020/4215/6885/5599/9261/4790/4792/5295/5296/5335/5590/5966/5970/8878/23118/257397/7334	30
WP2453	TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc)	9/3223	16/5488	0.679340841086458	0.999496944584873	0.999496944584873	47/48/1738/2271/3417/3419/4967/5160/6389	9
WP3287	Overview of nanoparticle effects	9/3223	16/5488	0.679340841086458	0.999496944584873	0.999496944584873	596/896/1001/1282/2335/3569/4798/5293/7124	9
WP3413	NOTCH1 regulation of endothelial cell calcification	9/3223	16/5488	0.679340841086458	0.999496944584873	0.999496944584873	813/54567/3672/182/3714/4851/5327/55553/7422	9
WP3967	miR-509-3p alteration of YAP1/ECM axis	9/3223	16/5488	0.679340841086458	0.999496944584873	0.999496944584873	1281/1909/2335/10082/5090/7003/7004/7058/10413	9
WP3527	Pre-implantation embryo	18/3223	32/5488	0.681851054002061	0.999496944584873	0.999496944584873	360/366/476/1875/1958/2354/2624/2625/3662/9314/57504/4084/4603/5087/5460/6597/30812/7004	18
WP4564	Neural crest cell migration during development	18/3223	32/5488	0.681851054002061	0.999496944584873	0.999496944584873	208/1009/2048/2051/2353/3725/4313/4318/4804/5290/5293/5294/8503/23533/146850/6774/7074/7204	18
WP3931	Embryonic stem cell pluripotency pathways	46/3223	81/5488	0.682700621860655	0.999496944584873	0.999496944584873	10097/208/369/8312/673/1499/1855/1856/1857/1956/2254/2260/2263/2264/2353/8321/7976/8323/8325/2549/2885/6927/3265/3716/3725/3977/4040/5604/5605/5607/5608/6300/5597/5155/5156/5293/5296/5728/4090/4091/4093/6774/7482/54361/7474/81029	46
WP4787	Osteoblast differentiation and related diseases	50/3223	88/5488	0.684548416901257	0.999496944584873	0.999496944584873	1499/54567/2254/2260/2263/2264/8321/7976/8323/8325/54626/55502/23462/182/3714/4040/5600/6300/5603/5597/5599/4851/4853/5287/5288/5290/5293/5294/5295/5296/8503/23533/146850/5468/5579/5580/5581/5583/5588/5590/5587/5727/860/4090/4093/6772/7482/54361/7474/81029	50
WP4239	Epithelial to mesenchymal transition in colorectal cancer	69/3223	121/5488	0.685089823922534	0.999496944584873	0.999496944584873	208/9076/24146/51208/1364/1366/9073/1282/1284/1285/1286/1287/1288/1499/54567/1832/8726/56648/2146/114793/2335/2305/8321/7976/8323/8325/9518/2885/3265/3398/182/3714/4040/5604/5605/5608/5600/6300/5603/5599/4209/4313/4318/4851/4853/80224/5290/5293/5295/5296/8503/5310/5318/5928/6464/4088/11171/23512/7040/7043/7082/56649/7157/7991/7482/54361/7474/81029/6935	69
WP5224	2q37 copy number variation syndrome	54/3223	95/5488	0.686520115500793	0.999496944584873	0.999496944584873	19/116987/51281/50636/10123/51665/23192/10203/801/805/11132/1293/6387/7852/9267/9266/9265/27128/728294/8527/285193/1915/1956/64090/10691/3069/55502/55355/3597/3553/80895/84289/3394/3690/3705/3725/84557/81631/4205/4208/151507/4644/4792/23178/5133/6194/10325/58528/23677/10494/7124/7157/7187/140739	54
WP707	DNA damage response	35/3223	62/5488	0.691810888770016	0.999496944584873	0.999496944584873	317/472/545/27113/836/842/595/896/9134/995/1017/1020/1021/1111/1385/54205/2177/355/1647/10912/4609/5366/5810/5884/10111/5893/5883/5981/6118/50484/2810/8243/9874/11011/7157	35
WP1403	AMP-activated protein kinase (AMPK) signaling	31/3223	55/5488	0.691819696189563	0.999496944584873	0.999496944584873	31/79602/208/51719/1374/200186/1938/29904/1978/2194/3156/5209/5290/5293/5294/5295/5296/8503/133522/5563/5564/5567/51422/6198/57521/6517/6794/55437/7157/7248/7249	31
WP363	Wnt signaling pathway	27/3223	48/5488	0.692603443531361	0.999496944584873	0.999496944584873	8312/8313/607/595/1021/1454/1487/1499/1855/1856/1857/10023/51176/4040/6885/5599/4609/4773/51701/55361/5468/5579/6929/6925/7010/7248/7249	27
WP3942	PPAR signaling pathway	27/3223	48/5488	0.692603443531361	0.999496944584873	0.999496944584873	2181/51703/345/364/1374/1593/1622/2169/2170/2167/2172/9415/3158/4023/4312/10062/5106/5360/5465/5467/5468/6257/6319/6342/376497/10999/10580	27
WP2586	Aryl hydrocarbon receptor pathway	23/3223	41/5488	0.694534074618829	0.999496944584873	0.999496944584873	57491/9049/405/11140/1017/1956/2033/2729/27306/3265/1316/4023/5604/4609/135112/9612/4790/5325/84722/5970/5979/7124/7422	23
WP405	Eukaryotic transcription initiation	23/3223	41/5488	0.694534074618829	0.999496944584873	0.999496944584873	902/1022/2068/2071/2960/2961/2963/2966/728340/84172/51082/64425/5430/5436/55703/661/55718/171568/51728/6883/6884/6878/6879	23
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	19/3223	34/5488	0.698247132022855	0.999496944584873	0.999496944584873	9744/9447/22900/834/838/842/1147/50506/3551/8517/3606/3553/4210/4792/22861/64127/639/5970/8767	19
WP1471	Target of rapamycin (TOR) signaling	19/3223	34/5488	0.698247132022855	0.999496944584873	0.999496944584873	54541/1978/2280/3156/3422/79109/5563/5564/51422/55615/79899/253260/6198/57521/10325/58528/7248/7249/8408	19
WP4533	Transcription co-factors SKI and SKIL protein partners	10/3223	18/5488	0.69924257012168	0.999496944584873	0.999496944584873	3065/8841/3622/4204/23314/25942/6498/6788/7003/7004	10
WP5181	Roles of ceramides in the development of insulin resistance	10/3223	18/5488	0.69924257012168	0.999496944584873	0.999496944584873	3667/8660/5599/5295/5590/6198/6517/7124/7132/7185	10
WP3888	VEGFA-VEGFR2 signaling pathway	231/3223	401/5488	0.701451041553785	0.999496944584873	0.999496944584873	31/23597/71/8754/9510/56999/154796/81575/378/22899/405/81873/10973/529/596/598/274/23476/682/811/813/824/867/115098/595/9578/84952/1192/1267/22820/1385/1387/1445/1465/1466/1495/1499/1500/1536/54205/1666/54567/11080/4189/1796/1958/1960/83939/9451/8664/8665/8667/1981/2022/2035/1969/2048/2060/2113/8772/10056/355/152273/2274/29109/2317/2321/91010/2335/2308/4303/6624/2534/2549/2597/2624/10755/2746/2885/2926/1839/3065/10014/51564/9734/9146/3146/3265/3303/3315/10525/3418/51278/3486/8821/51763/3685/3690/182/3725/23189/3791/9365/3939/3984/3998/55379/55692/5604/5605/5608/5609/4217/6300/5599/79109/9261/4208/4319/4313/79812/4343/4627/4641/4646/4673/653361/4690/91624/4772/4773/4790/4792/4846/3164/4929/8013/441478/8650/8974/5034/26986/55872/10130/5216/5226/5290/5295/5296/5321/5328/5329/5331/5335/5496/5499/5530/7001/9588/5563/5579/5580/5581/5590/5587/25865/5592/23215/2185/5757/5770/5777/5780/326624/5867/5906/5908/2889/9584/5954/5970/57381/253260/27289/6093/4736/23521/6142/6155/6125/6129/6181/6205/6194/9252/6198/1901/23753/80031/6418/83442/6464/357/6478/6541/6546/6595/6722/6729/6747/8027/6772/6774/6886/6902/7004/7024/7111/9168/7114/8794/8718/7148/10758/7295/10628/9100/7414/7422/23339/7531	231
WP3998	Prader-Willi and Angelman syndrome	15/3223	27/5488	0.704928577344746	0.999496944584873	0.999496944584873	585/595/990/1021/1030/1031/9638/2562/8924/4194/81614/5122/5590/7157/114791	15
WP2882	Nuclear receptors meta-pathway	143/3223	250/5488	0.715775695976866	0.999496944584873	0.999496944584873	5243/5244/8714/10057/177/57491/9049/11214/218/347902/345/221079/405/84002/8553/329/330/645/10486/873/874/6364/595/11140/10602/1028/8824/283848/1374/1557/1576/1551/1622/3337/29103/7266/1956/1958/8507/2033/1969/2194/121512/9982/2289/2308/2512/79571/2729/2730/2678/387509/2878/2936/2941/2948/2950/1839/3326/3303/3553/8660/3725/3727/55554/3895/56262/23764/4240/4257/4258/4609/26509/8202/4791/10062/9971/5142/5155/5166/5226/10769/5360/5460/5465/5467/10891/81706/5052/9588/22949/5997/6286/6319/6337/6342/6397/5265/5272/9792/1836/376497/6513/66035/154091/114134/6517/6518/11182/56606/57181/91252/29985/55630/283375/25800/64116/6523/115584/6526/8884/160728/11254/340024/54716/6536/8243/6649/10252/8878/6774/2040/6817/6822/7039/7040/7049/7056/7124/7128/1831/7295/114112	143
WP4255	Non-small cell lung cancer	37/3223	66/5488	0.716681042240758	0.999496944584873	0.999496944584873	208/369/572/673/836/842/595/1021/54205/1870/1956/2272/1647/10912/2885/3265/3718/5604/5605/5290/5293/5295/5296/8503/5335/5336/5579/5915/11186/83593/6257/6774/6776/6777/6789/7039/7157	37
WP2878	PPAR-alpha pathway	11/3223	20/5488	0.717093475106818	0.999496944584873	0.999496944584873	345/595/1374/1622/55554/4609/10062/5360/5465/6342/376497	11
WP3580	Methionine de novo and salvage pathway	11/3223	20/5488	0.717093475106818	0.999496944584873	0.999496944584873	51074/55349/259307/84245/4482/22921/253827/4548/4953/6898/7295	11
WP3640	Imatinib and chronic myeloid leukemia	11/3223	20/5488	0.717093475106818	0.999496944584873	0.999496944584873	5243/613/1436/2321/1647/3815/4066/4609/4839/5156/11040	11
WP4224	Purine metabolism and related disorders	11/3223	20/5488	0.717093475106818	0.999496944584873	0.999496944584873	100/158/353/471/1716/3251/3614/10606/5631/50484/7498	11
WP4494	Selective expression of chemokine receptors during T-cell polarization	11/3223	20/5488	0.717093475106818	0.999496944584873	0.999496944584873	1233/1236/940/920/959/7852/3460/8809/3566/7040/7043	11
WP5053	Development of ureteric collection system	25/3223	45/5488	0.722789510173138	0.999496944584873	0.999496944584873	653/655/168667/595/9620/1499/2118/2263/80144/2625/2674/2719/3207/8516/5087/5915/5916/5979/6091/6092/6299/6469/9353/10252/57216	25
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	6/3223	11/5488	0.724887739321786	0.999496944584873	0.999496944584873	1499/2308/6422/4090/4093/54361	6
WP4947	Nitric oxide metabolism in cystic fibrosis	6/3223	11/5488	0.724887739321786	0.999496944584873	0.999496944584873	23576/23564/4843/4846/55170/54496	6
WP5049	Glycolysis in senescence	6/3223	11/5488	0.724887739321786	0.999496944584873	0.999496944584873	230/2023/2597/3098/3939/7157	6
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	6/3223	11/5488	0.724887739321786	0.999496944584873	0.999496944584873	2048/2358/1241/5290/5293/5294	6
WP692	Sulfation biotransformation reaction	6/3223	11/5488	0.724887739321786	0.999496944584873	0.999496944584873	2936/9061/9060/6817/6819/6822	6
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	21/3223	38/5488	0.727736624322383	0.999496944584873	0.999496944584873	208/775/814/1742/1978/3265/4915/5290/5293/5295/5296/8503/5563/5564/51422/5728/6198/57521/8831/7248/7249	21
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	12/3223	22/5488	0.733255074202537	0.999496944584873	0.999496944584873	8714/2052/2353/2729/2730/2950/3725/5600/6300/5603/5599/4835	12
WP4148	Splicing factor NOVA regulated synaptic proteins	17/3223	31/5488	0.735496790809169	0.999496944584873	0.999496944584873	334/490/57863/8573/23332/22883/1946/2035/2036/2037/23136/10243/3778/23154/5332/5590/54386	17
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	22/3223	40/5488	0.741045458416115	0.999496944584873	0.999496944584873	59/71/72/1495/1499/3689/3690/3694/8994/11184/5871/8491/9448/11183/5599/4485/4771/6788/7003/7004/10971/55249	22
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	7/3223	13/5488	0.741288788601268	0.999496944584873	0.999496944584873	2353/3551/3725/4312/4790/4792/7422	7
WP4705	Pathways of nucleic acid metabolism and innate immune sensing	7/3223	13/5488	0.741288788601268	0.999496944584873	0.999496944584873	23586/3661/4938/79621/84153/8635/11277	7
WP5115	Network map of SARS-CoV-2 signaling pathway	102/3223	180/5488	0.742303822876758	0.999496944584873	0.999496944584873	59272/71/341/347/8542/55937/708/814/84433/836/838/842/6356/6359/6364/6366/6352/929/9332/919/916/917/920/925/1051/629/3075/5199/1294/1514/6387/10563/58191/2920/2921/6372/4283/3577/3579/54541/23586/1958/1978/2335/2353/2534/2811/2934/3043/3123/10964/2537/3434/8519/10410/3486/8517/3603/3606/8807/3552/3553/7850/90865/3569/3574/3654/3661/3699/3716/3725/3932/3959/81631/5599/4791/55922/22861/5588/5777/6194/57521/6237/6288/6289/5104/8631/4090/6772/55240/7124/8743/7186/7187/7226/8408/57617/65082/51028/27072/54663/7535	102
WP4659	Gastrin signaling pathway	60/3223	107/5488	0.746979436721283	0.999496944584873	0.999496944584873	64283/572/598/329/330/836/595/1113/1147/9076/1385/1499/1956/1958/1978/2353/2308/2534/2776/2885/51564/3067/3265/3551/3667/182/3725/3815/9314/5604/5599/4208/4209/4316/4609/4790/4792/5290/5295/5296/8503/5335/5468/5580/5581/5583/5588/5587/25865/5970/6093/6194/6198/6464/6548/6774/6925/7082/7422/7525	60
WP5124	Alzheimer's disease	118/3223	208/5488	0.748674587300131	0.999496944584873	0.999496944584873	6868/11047/177/208/55626/317/322/51107/83464/348/369/488/489/8312/8313/23621/572/673/775/801/805/808/91860/823/824/836/842/1020/8851/1147/1435/1454/1459/1499/1536/54205/1855/1856/1857/9451/8772/355/10023/23401/8321/7976/8323/8325/2597/2776/3265/3028/3416/3551/3552/3553/3569/3667/8660/3708/3709/3800/3831/64837/4023/4040/5604/5605/5609/4217/5599/23385/4790/4843/27035/5290/5293/5295/5296/8503/5330/5331/5332/5530/5533/5534/5663/5664/5683/5684/5685/5686/5687/5689/5690/5709/5970/10313/57142/292/293/7124/7132/7186/7277/79861/203068/7280/347733/10381/8408/7419/26100/7482/54361/7474/81029/7494	118
WP422	MAPK cascade	18/3223	33/5488	0.749099629643737	0.999496944584873	0.999496944584873	369/673/2885/3265/3725/4133/5604/5605/5608/5609/4214/7786/4215/6300/5331/22821/6237/6494	18
WP1530	miRNA regulation of DNA damage response	36/3223	65/5488	0.752063683984383	0.999496944584873	0.999496944584873	317/472/545/27113/836/842/595/896/9134/900/995/1017/1020/1021/1111/1385/54205/2177/355/1647/10912/4609/5366/5810/5884/10111/5893/5883/5981/6118/50484/2810/8243/9874/11011/7157	36
WP2059	Alzheimer's disease and miRNA effects	119/3223	210/5488	0.755559478882473	0.999496944584873	0.999496944584873	6868/11047/177/208/55626/317/322/51107/83464/348/369/488/489/8312/8313/23621/572/673/775/801/805/808/91860/823/824/836/842/1020/8851/54480/1147/1435/1454/1459/1499/1536/54205/1855/1856/1857/9451/8772/355/10023/23401/8321/7976/8323/8325/2597/2776/3265/3028/3416/3551/3552/3553/3569/3667/8660/3708/3709/3800/3831/64837/4023/4040/5604/5605/5609/4217/5599/23385/4790/4843/27035/5290/5293/5295/5296/8503/5330/5331/5332/5530/5533/5534/5663/5664/5683/5684/5685/5686/5687/5689/5690/5709/5970/10313/57142/292/293/7124/7132/7186/7277/79861/203068/7280/347733/10381/8408/7419/26100/7482/54361/7474/81029/7494	119
WP1545	miRNAs involved in DNA damage response	8/3223	15/5488	0.756060313019027	0.999496944584873	0.999496944584873	472/595/896/1021/1385/4609/5893/7157	8
WP1742	TP53 network	8/3223	15/5488	0.756060313019027	0.999496944584873	0.999496944584873	472/27113/596/1647/4609/5366/8743/7157	8
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	8/3223	15/5488	0.756060313019027	0.999496944584873	0.999496944584873	23086/8567/25924/84958/54843/94120/83874/201294	8
WP3	Transcriptional activation by NRF2 in response to phytochemicals	8/3223	15/5488	0.756060313019027	0.999496944584873	0.999496944584873	7965/1051/2048/2729/2730/4094/5599/5290	8
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	8/3223	15/5488	0.756060313019027	0.999496944584873	0.999496944584873	8312/1499/1856/8321/8325/51176/154141/6925	8
WP5149	Lipid metabolism in senescent cells	8/3223	15/5488	0.756060313019027	0.999496944584873	0.999496944584873	240/3265/8399/26279/5321/8398/7941/7157	8
WP1422	Sphingolipid pathway	14/3223	26/5488	0.761524155981405	0.999496944584873	0.999496944584873	56624/64781/29956/79603/91012/253782/2629/2531/5499/166929/8877/56848/9517/7368	14
WP2525	Trans-sulfuration and one-carbon metabolism	14/3223	26/5488	0.761524155981405	0.999496944584873	0.999496944584873	10768/23382/875/1491/1786/1788/2729/2730/4522/441024/4548/26227/29968/6470	14
WP4204	Tumor suppressor activity of SMARCB1	14/3223	26/5488	0.761524155981405	0.999496944584873	0.999496944584873	8289/57492/1021/5977/8726/2146/2738/5727/5928/6597/6598/6601/6602/23512	14
WP4838	Regucalcin in proximal tubule epithelial kidney cells	14/3223	26/5488	0.761524155981405	0.999496944584873	0.999496944584873	59/317/673/836/842/10146/4217/5290/5534/5588/5970/7040/7132/8600	14
WP167	Eicosanoid synthesis	9/3223	17/5488	0.769491828755759	0.999496944584873	0.999496944584873	246/240/1800/2678/5320/5321/8398/50640/5730	9
WP4912	SARS coronavirus and innate immunity	9/3223	17/5488	0.769491828755759	0.999496944584873	0.999496944584873	59272/23586/9641/3661/3716/6772/7098/7187/7297	9
WP2828	Bladder cancer	20/3223	37/5488	0.773543916174984	0.999496944584873	0.999496944584873	369/673/595/1956/1839/3265/5604/5605/4312/4313/4318/4609/5295/5296/11186/9252/7057/7157/1890/7422	20
WP1601	Fluoropyrimidine activity	15/3223	28/5488	0.774000326951271	0.999496944584873	0.999496944584873	8714/10057/8824/1806/2068/8836/6240/2030/23583/6996/7157/1890/83549/7378/7517	15
WP2363	Gastric cancer network 2	15/3223	28/5488	0.774000326951271	0.999496944584873	0.999496944584873	29028/962/54921/1499/1956/157769/55215/3930/4609/5884/5983/5984/255488/6277/7157	15
WP716	Vitamin A and carotenoid metabolism	15/3223	28/5488	0.774000326951271	0.999496944584873	0.999496944584873	216/8854/56603/8694/4023/29881/5915/5916/5948/5950/54884/6257/949/195814/6817	15
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	138/3223	244/5488	0.780071699122331	0.999496944584873	0.999496944584873	31/208/1388/572/51719/81617/842/11140/1280/1281/1282/1284/1286/1288/1290/1385/10488/90993/84699/9586/200186/1435/1436/1440/1441/54541/1944/1946/1956/1975/9470/1978/1969/2149/2254/2260/2263/2264/2321/2335/2308/2690/2782/2783/55970/54331/2788/2793/2885/3265/3326/7184/3480/3551/8517/3560/3561/3563/3566/3570/3667/8660/3676/3655/3679/8516/3680/3682/3683/3685/3687/3689/3690/3694/3716/3718/3791/3815/4254/3908/3910/3911/3912/3915/3918/10319/9170/57121/5604/5605/4804/4843/4846/5155/56034/80310/5156/53918/5209/23035/5287/5290/5293/5294/113791/5295/5296/23533/10891/5516/5523/5526/5527/5528/5563/5728/9230/5862/6194/6198/57521/6513/6517/6696/6794/23216/8115/7010/7057/7058/7059/3371/7148/7248/7249/8408/7422/7423	138
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	10/3223	19/5488	0.781795080999168	0.999496944584873	0.999496944584873	941/942/3939/4609/5160/5290/5563/5970/7248/7249	10
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	10/3223	19/5488	0.781795080999168	0.999496944584873	0.999496944584873	1267/2920/3553/5155/5354/6469/6660/55553/30812/7124	10
WP727	Monoamine transport	10/3223	19/5488	0.781795080999168	0.999496944584873	0.999496944584873	995/3553/3690/5516/5934/6804/6999/7124/4982/7249	10
WP2526	PDGF pathway	21/3223	39/5488	0.784570352360583	0.999496944584873	0.999496944584873	1147/2353/2885/3265/3716/3725/5604/4214/5599/4790/4792/5155/5295/5321/5335/6464/6722/6772/6774/7074/7409	21
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	21/3223	39/5488	0.784570352360583	0.999496944584873	0.999496944584873	109/111/113/115/8815/2885/3265/3930/5604/5605/4293/5339/4088/6722/23345/23224/161176/7040/7043/7112/55249	21
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	16/3223	30/5488	0.785555245176716	0.999496944584873	0.999496944584873	59272/23586/9641/51135/3661/3716/4938/6772/7098/7099/10333/51284/54106/7113/7187/7297	16
WP4806	EGFR tyrosine kinase inhibitor resistance	44/3223	80/5488	0.787792949196675	0.999496944584873	0.999496944584873	208/369/558/572/596/598/673/595/1956/9470/1978/2263/2549/2885/3265/3480/3569/3570/3716/3791/5604/5605/22808/4609/5155/56034/80310/5156/5290/5293/5295/5296/8503/5335/5336/5579/5728/6194/6198/6237/6464/6774/7039/7422	44
WP3658	Wnt/beta-catenin signaling pathway in leukemia	11/3223	21/5488	0.793130878081258	0.999496944584873	0.999496944584873	8313/607/595/1499/2322/8323/51176/4040/4609/5467/6929	11
WP4861	Endoplasmic reticulum stress response in coronavirus infection	22/3223	41/5488	0.794900744918236	0.999496944584873	0.999496944584873	596/9451/3309/84557/5599/8720/5499/5514/4659/4660/54776/26472/81706/54866/23645/26051/5509/90673/5511/55607/84687/7494	22
WP4803	Ciliopathies	70/3223	126/5488	0.795264472740506	0.999496944584873	0.999496944584873	54806/122481/7840/124401/203286/200894/23568/403/25814/27077/80776/79738/166379/585/27241/26005/79140/22897/84984/80184/95681/55172/83544/51626/114327/84140/84662/23432/55764/9742/26160/11020/112752/51098/55081/57560/28981/56623/27130/9657/9786/9851/167691/54585/4751/284086/91754/8481/5147/10464/5310/25886/9364/89765/10806/6674/51684/202018/221322/79600/79867/84314/51524/51259/146057/9094/51057/57728/63929/23090	70
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	66/3223	119/5488	0.795959389036401	0.999496944584873	0.999496944584873	6868/572/814/836/1020/8851/1147/1268/1385/23373/1499/1938/1958/1959/1978/2353/2534/2562/2885/3265/3551/8517/3667/8660/3725/3738/5604/5605/5607/4214/5599/4082/4205/4208/653361/4690/8440/4790/4792/4804/4915/5295/5296/5335/5563/5580/2185/5906/5923/5970/6194/9252/6198/25970/6464/6272/6696/8878/6772/6774/6776/6777/7074/7249/10451/4904	66
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	27/3223	50/5488	0.796372474602419	0.999496944584873	0.999496944584873	208/9134/1017/1105/1106/1956/2321/3791/5604/5605/4313/4318/4790/4791/8829/5361/5362/5966/5970/5971/10371/55630/4088/7040/7043/7049/7422	27
WP236	Adipogenesis	58/3223	105/5488	0.798160328603994	0.999496944584873	0.999496944584873	649/651/1051/1052/10658/1675/55847/1385/1499/56603/1855/1874/1879/1959/355/2308/2487/8321/1647/2624/2625/6927/3399/3569/3667/8660/1316/3977/23175/64900/4023/4154/4205/4208/4209/4282/9612/10062/5106/5465/5467/5468/10891/5934/6319/6517/4088/8651/9021/6695/6772/6774/6776/6777/7040/7124/57761/81029	58
WP2118	Arrhythmogenic right ventricular cardiomyopathy	28/3223	52/5488	0.805603292475726	0.999496944584873	0.999496944584873	71/488/775/9254/93589/782/783/784/1495/1499/1674/1832/3672/3676/3655/3679/8516/3680/3685/3690/3694/3908/51176/5318/6443/6444/6546/6932	28
WP3680	Physico-chemical features and toxicity-associated pathways	28/3223	52/5488	0.805603292475726	0.999496944584873	0.999496944584873	10097/10096/8312/867/1499/23002/1855/1956/2335/8321/7976/8323/8325/2885/3725/5604/5599/4609/4690/5216/5217/5294/5335/6464/6647/6776/7039/7114	28
WP313	Hepatocyte growth factor receptor signaling	18/3223	34/5488	0.806308689467229	0.999496944584873	0.999496944584873	1793/2353/2549/2885/3265/3672/3725/5604/5605/11184/5599/5290/5728/2185/5906/5908/2889/6774	18
WP45	G1 to S cell cycle control	33/3223	61/5488	0.808106804227344	0.999496944584873	0.999496944584873	1388/472/595/896/9134/901/902/1017/1021/1022/1028/1030/1031/1032/1385/10488/90993/84699/1870/1647/4171/4172/4174/4609/23595/5426/5427/6117/6118/7027/7029/7157/7465	33
WP4321	Thermogenesis	51/3223	93/5488	0.809452800429885	0.999496944584873	0.999496944584873	2181/51703/71/109/111/113/115/8289/57492/1268/1374/1385/10488/90993/84699/9586/2260/2641/2778/2885/3265/51780/4217/5600/6300/5603/11343/5468/10891/5563/5564/5567/51422/5592/5593/6194/6196/27330/6198/57521/51548/788/123096/6595/6597/6598/6601/6602/7248/7249/9658	51
WP4549	Fragile X syndrome	51/3223	93/5488	0.809452800429885	0.999496944584873	0.999496944584873	5825/116986/9495/7915/163/369/9743/673/814/1212/1268/1374/1385/26999/1742/1759/1785/1845/1915/1981/2043/54869/2332/2534/2549/2561/10243/2885/3708/4131/5604/5605/4204/4318/4915/5335/5499/5526/5530/5573/5728/6198/57521/6464/6566/8831/6895/9524/7248/7249/9675	51
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	5/3223	10/5488	0.811920914977088	0.999496944584873	0.999496944584873	4318/4609/9021/6774/7157	5
WP4259	Disorders of folate metabolism and transport	5/3223	10/5488	0.811920914977088	0.999496944584873	0.999496944584873	10840/471/4522/4548/113235	5
WP4589	Major receptors targeted by epinephrine and norepinephrine	5/3223	10/5488	0.811920914977088	0.999496944584873	0.999496944584873	109/111/113/115/150	5
WP4942	15q13.3 copy number variation syndrome	5/3223	10/5488	0.811920914977088	0.999496944584873	0.999496944584873	6352/1387/22909/2177/2534	5
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	5/3223	10/5488	0.811920914977088	0.999496944584873	0.999496944584873	718/629/1675/23463/9986	5
WP4566	Translation inhibitors in chronically activated PDGFRA cells	24/3223	45/5488	0.8137169203294	0.999496944584873	0.999496944584873	208/1975/1978/1981/8672/5604/5605/5607/5608/5609/5599/27250/5290/5294/5295/5296/8503/11040/5580/6194/6196/9252/6198/57521	24
WP47	Hedgehog signaling pathway	6/3223	12/5488	0.818637369650019	0.999496944584873	0.999496944584873	406/5727/6469/25942/27148/51684	6
WP3996	Ethanol effects on histone modifications	14/3223	27/5488	0.822473240667038	0.999496944584873	0.999496944584873	55902/125/216/8854/217/10919/55140/3065/8841/10014/51564/9734/4548/6573	14
WP4561	Cell migration and invasion through p75NTR	14/3223	27/5488	0.822473240667038	0.999496944584873	0.999496944584873	11093/208/1009/1944/1946/1948/3725/4313/4318/4804/4915/6774/7074/7204	14
WP534	Glycolysis and gluconeogenesis	20/3223	38/5488	0.824440907122318	0.999496944584873	0.999496944584873	230/1738/2023/2026/2027/2597/2805/2821/3098/3099/3939/3945/4191/5160/5213/5223/6513/6517/6518/7167	20
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	7/3223	14/5488	0.825693094094805	0.999496944584873	0.999496944584873	595/1466/1499/182/5469/5366/6659	7
WP4159	GABA receptor signaling	7/3223	14/5488	0.825693094094805	0.999496944584873	0.999496944584873	163/2550/2561/2562/2564/2568/10243	7
WP4225	Pyrimidine metabolism and related diseases	7/3223	14/5488	0.825693094094805	0.999496944584873	0.999496944584873	1723/1806/5009/6240/50484/7084/1890	7
WP4921	Mitochondrial complex III assembly	7/3223	14/5488	0.825693094094805	0.999496944584873	0.999496944584873	617/90624/54902/55245/7385/7386/27089	7
WP4928	MAPK pathway in congenital thyroid cancer	7/3223	14/5488	0.825693094094805	0.999496944584873	0.999496944584873	673/2353/3725/5604/5605/4609/6464	7
WP4262	Breast cancer pathway	63/3223	115/5488	0.832638673578048	0.999496944584873	0.999496944584873	208/369/472/545/8312/8313/673/595/1021/1070/1459/1499/54567/1855/1856/1857/1870/1956/2254/2260/2353/10023/23401/8321/7976/8323/8325/1647/10912/2885/23462/3265/3480/3714/3725/3815/51176/4040/5604/5605/4609/8202/4791/4851/4853/142/5290/5293/5295/5296/8503/5728/10111/6198/6464/6500/6932/8600/7157/7482/54361/7474/81029	63
WP4205	MET in type 1 papillary renal cell carcinoma	27/3223	51/5488	0.83805682408512	0.999496944584873	0.999496944584873	208/369/572/673/867/2113/2549/2885/3265/3718/3725/5604/5605/5599/5290/5293/5295/5296/8503/5335/5546/5906/5908/2889/6135/6774/7030	27
WP437	EGF/EGFR signaling pathway	85/3223	154/5488	0.838066404217985	0.999496944584873	0.999496944584873	10006/163/9138/466/673/867/868/1385/1445/1759/1956/1978/2005/2060/58513/2353/2354/2308/4303/2549/2885/9146/3265/3635/3636/9922/3716/3725/3727/3985/5604/5605/5607/4214/4215/4216/11184/5599/4205/4208/4209/4605/4690/8440/8202/4734/4846/5037/10401/5287/5295/5296/51196/5335/5337/5338/5359/5579/5580/5590/5728/2185/7837/10928/5906/9185/253260/9610/6093/6196/9252/6198/30011/6464/10253/8027/6772/6774/6776/6777/3925/10188/9712/7409/10451	85
WP34	Ovarian infertility	9/3223	18/5488	0.839741087389838	0.999496944584873	0.999496944584873	472/1051/1958/2701/5732/4088/6609/23224/7784	9
WP3670	Interactions between LOXL4 and oxidative stress pathway	9/3223	18/5488	0.839741087389838	0.999496944584873	0.999496944584873	11140/1280/780/2335/84171/4899/5310/23411/7040	9
WP5103	Progeria-associated lipodystrophy	9/3223	18/5488	0.839741087389838	0.999496944584873	0.999496944584873	8815/23463/142/5424/5468/5965/4088/83932/7040	9
WP4541	Hippo-Merlin signaling dysregulation	51/3223	94/5488	0.839949041901379	0.999496944584873	0.999496944584873	84962/154796/595/1009/28513/1001/1436/1495/1499/1956/1969/2260/2263/2264/2321/2322/2305/3265/3480/3672/3676/3655/3679/8516/3680/3682/3683/3684/3685/3687/3689/3690/3694/3791/3815/4485/4609/4771/4804/4915/5156/5332/5499/4659/5567/5573/6788/7003/7004/7010/55249	51
WP3594	Circadian rhythm genes	78/3223	142/5488	0.845609918660981	0.999496944584873	0.999496944584873	100/405/9915/406/8553/79365/57805/1364/1374/1385/23373/1407/1408/1454/1628/1644/1655/1859/1958/1960/2033/2146/355/2673/2767/2776/3065/8841/50865/3398/3399/3400/3569/3725/3727/3778/5927/687/4297/5599/56339/9112/4804/4843/4862/9572/9975/10062/8473/23596/5187/8863/5465/5468/10891/5499/5551/5563/5593/60675/5728/5730/10743/5936/83759/5971/6097/6233/23064/25942/23411/6500/9967/8792/7150/7157/7311/9099	78
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	10/3223	20/5488	0.846496686891519	0.999496944584873	0.999496944584873	596/597/598/83596/23786/79370/440603/3655/4609/5294	10
WP2361	Gastric cancer network 1	11/3223	22/5488	0.85300668195998	0.999496944584873	0.999496944584873	55125/144455/1894/54891/56992/4605/4851/57122/54476/8607/6286	11
WP4324	Mitochondrial complex I assembly model OXPHOS system	24/3223	46/5488	0.854611702630067	0.999496944584873	0.999496944584873	28976/55744/4694/4698/4700/4701/4706/51103/91942/137682/55471/54539/4708/4709/4710/4711/4712/4719/4724/4723/80224/51300/55863/25880	24
WP4022	Pyrimidine metabolism	40/3223	75/5488	0.858329352535811	0.999496944584873	0.999496944584873	1503/1633/1635/79077/1723/1806/1854/5167/5169/956/4830/4833/87178/5424/5425/57804/5426/5427/84172/9533/51082/64425/5430/5433/5436/55703/661/55718/10621/10622/84265/171568/51728/6240/50484/7084/1890/83549/54963/7378	40
WP2406	Cardiac progenitor differentiation	12/3223	24/5488	0.859253559153046	0.999496944584873	0.999496944584873	290/649/7852/3481/3624/3791/3815/4208/4851/5156/5460/7040	12
WP4698	Vitamin D-sensitive calcium signaling in depression	12/3223	24/5488	0.859253559153046	0.999496944584873	0.999496944584873	490/596/775/1593/2729/2678/2936/3708/3709/3786/221656/6546	12
WP4925	Unfolded protein response	12/3223	24/5488	0.859253559153046	0.999496944584873	0.999496944584873	27113/596/835/9451/3309/3553/8720/5366/23645/7157/10628/7494	12
WP4536	Genes related to primary cilium development (based on CRISPR)	45/3223	84/5488	0.859546867343976	0.999496944584873	0.999496944584873	200894/403/27077/79738/166379/585/27241/26005/84984/55125/80817/79598/51626/6993/84455/80199/51668/55764/9742/26160/90410/11020/112752/56912/51098/55081/57560/28981/56623/9851/11127/54585/57534/8481/10464/11159/79600/79867/84314/51259/146057/51174/51175/51057/57728	45
WP5085	Vasopressin-regulated water reabsorption	19/3223	37/5488	0.860135519687443	0.999496944584873	0.999496944584873	109/115/360/397/1385/10488/90993/84699/9586/51164/84516/1781/51626/2778/5567/9230/5869/6810/6844	19
WP2272	Pathogenic Escherichia coli infection	25/3223	48/5488	0.861119762064832	0.999496944584873	0.999496944584873	71/9181/10109/10094/10093/81873/929/9076/1499/2534/3059/23643/4690/8440/6093/7099/7100/7277/79861/203068/7280/347733/10381/7454/10971	25
WP3869	Cannabinoid receptor signaling	13/3223	26/5488	0.865232536215961	0.999496944584873	0.999496944584873	113/1268/1269/1557/1576/221955/2166/5600/6300/5603/5599/5567/5573	13
WP5122	Prostaglandin and leukotriene metabolism in senescence 	13/3223	26/5488	0.865232536215961	0.999496944584873	0.999496944584873	109/246/240/10800/2776/2778/3265/5600/5321/5730/5732/5733/23411	13
WP4217	Ebola virus infection in host	65/3223	120/5488	0.868407195769476	0.999496944584873	0.999496944584873	71/6868/558/708/30835/10462/1212/1387/1514/153090/23586/1956/2033/2060/2317/2934/26762/3105/3111/3112/3115/3117/3118/3119/3120/3123/3135/3384/3385/3480/9641/3661/3672/3676/3655/3685/3690/4240/4734/4790/4791/10577/5290/5293/5295/5296/8503/9367/5922/5966/5970/5971/5981/85477/9021/6772/7074/91937/7099/7150/7301/57617/65082/23339/27072	65
WP4685	Melanoma	32/3223	61/5488	0.870618978984816	0.999496944584873	0.999496944584873	208/369/572/673/801/805/808/91860/595/1021/1385/1870/2113/2353/1647/10912/2885/3265/3791/3815/5604/5605/5290/5293/5295/5296/8503/80243/5728/8859/7157/7414	32
WP170	Nuclear receptors	14/3223	28/5488	0.870946154382804	0.999496944584873	0.999496944584873	9975/7376/10062/3164/4929/2494/5465/5467/5468/5915/5916/6097/6257/7068	14
WP4844	Influence of laminopathies on Wnt signaling	15/3223	30/5488	0.876401145073002	0.999496944584873	0.999496944584873	8312/595/1021/1051/1052/1499/23463/51176/5468/860/6517/6696/6895/6932/7088	15
WP410	Exercise-induced circadian regulation	22/3223	43/5488	0.877956269223666	0.999496944584873	0.999496944584873	406/694/1051/1407/1408/2120/2674/2950/3422/687/10787/8031/9975/5187/5281/5516/5685/10946/23118/10140/10381/7360	22
WP5222	2q13 copy number variation syndrome	22/3223	43/5488	0.877956269223666	0.999496944584873	0.999496944584873	80117/150468/1435/10563/2625/2885/3552/3553/3569/5336/84172/9533/51082/64425/6574/8651/9021/6772/84910/150465/376940/84524	22
WP4946	DNA repair pathways, full network	59/3223	110/5488	0.883308670242541	0.999496944584873	0.999496944584873	27301/472/545/902/1022/1069/1111/8450/64421/2067/2068/2071/2072/9156/22909/2176/2177/2178/55215/2966/728340/3146/3978/3980/3981/8930/4255/4350/2956/4595/252969/55247/4913/4968/142/5395/5423/5424/5425/57804/5426/5427/5429/27343/27434/10111/5889/5893/5906/51455/5981/5983/5984/6117/6118/23583/6996/7014/7515	59
WP2289	Drug induction of bile acid pathway	5/3223	11/5488	0.884448561356507	0.999496944584873	0.999496944584873	5243/8714/1576/9971/6822	5
WP2290	RalA downstream regulated genes	5/3223	11/5488	0.884448561356507	0.999496944584873	0.999496944584873	55770/149371/3265/5880/10928	5
WP3871	Valproic acid pathway	5/3223	11/5488	0.884448561356507	0.999496944584873	0.999496944584873	3030/3032/3065/3028/3712	5
WP4707	Aspirin and miRNAs	5/3223	11/5488	0.884448561356507	0.999496944584873	0.999496944584873	114614/4790/4846/5465/7422	5
WP4210	Tryptophan catabolism leading to NAD+ production	6/3223	13/5488	0.884936153406091	0.999496944584873	0.999496944584873	51166/23498/8564/8942/55191/6999	6
WP4962	Airway smooth muscle cell contraction	6/3223	13/5488	0.884936153406091	0.999496944584873	0.999496944584873	801/805/952/2664/2776/6093	6
WP5037	Riboflavin and CoQ disorders	6/3223	13/5488	0.884936153406091	0.999496944584873	0.999496944584873	27235/2108/2110/23590/57107/55312	6
WP185	Integrin-mediated cell adhesion	45/3223	85/5488	0.885126975316813	0.999496944584873	0.999496944584873	208/369/8874/673/823/11132/824/827/23473/1445/1793/2534/2885/3265/3672/3676/3655/3679/8516/3680/3682/3683/3684/3685/3687/3689/3690/3694/5604/5605/5607/5608/6300/5597/5296/5880/5906/5908/2889/6093/6464/10580/7408/10451/7414	45
WP4249	Hedgehog signaling pathway	17/3223	34/5488	0.886572679200875	0.999496944584873	0.999496944584873	596/595/50937/1454/1455/8452/2619/23432/64399/11127/5567/5727/6469/57154/64750/339745/51684	17
WP43	Oxidation by cytochrome P450	17/3223	34/5488	0.886572679200875	0.999496944584873	0.999496944584873	1528/51706/1727/56603/1593/1557/1565/1573/29785/113612/51302/1576/1551/4051/285440/260293/5447	17
WP4240	Regulation of sister chromatid separation at the metaphase-anaphase transition	7/3223	15/5488	0.886621777536112	0.999496944584873	0.999496944584873	29882/9184/9700/8379/4085/5885/8243	7
WP100	Glutathione metabolism	8/3223	17/5488	0.88903574601456	0.999496944584873	0.999496944584873	290/2729/2730/2678/2687/2878/2936/3417	8
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	18/3223	36/5488	0.891310249448858	0.999496944584873	0.999496944584873	596/2353/8519/10410/3725/5604/5605/5608/5609/4214/4294/4216/4293/5600/6300/5603/5599/6196	18
WP4352	Ciliary landscape	106/3223	194/5488	0.89437092599726	0.999496944584873	0.999496944584873	2181/124401/203286/57136/26286/25852/585/27241/801/805/875/10421/64072/9859/80184/79598/25904/64708/1387/1488/1499/80344/1655/8526/23549/80005/1857/1781/83658/6993/6990/1892/80258/30845/55770/60412/10640/23233/23265/149371/23016/5393/80199/2664/54994/3065/51668/27429/55764/9742/26160/90410/11020/112752/56912/51098/55081/57560/28981/9657/10788/128239/167691/3934/25804/54585/10296/10982/4171/4172/4174/84515/254394/4236/140465/4698/284086/4790/22981/10726/55746/4927/10424/9883/5862/79874/57610/10432/64777/8732/6103/10051/2040/9882/7322/7328/55245/9217/7431/80232/7465/65125/63929/10413/51646/79699	106
WP4905	1q21.1 copy number variation syndrome	10/3223	21/5488	0.895011058537209	0.999496944584873	0.999496944584873	607/9557/1499/149013/5563/5564/51422/90780/7082/9414	10
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	26/3223	51/5488	0.897664531144582	0.999496944584873	0.999496944584873	348/8312/602/1495/2113/2149/2729/3065/3309/3315/3329/8870/3727/4790/5585/2185/8767/6198/9021/8878/7057/7124/27242/7185/10451/7431	26
WP3982	miRNA regulation of p53 pathway in prostate cancer	11/3223	23/5488	0.898273198650095	0.999496944584873	0.999496944584873	317/472/27113/836/842/9538/5366/5728/143686/7157/64393	11
WP4357	NRF2-ARE regulation	11/3223	23/5488	0.898273198650095	0.999496944584873	0.999496944584873	7965/1051/8452/2048/2534/2729/2730/4094/5599/5290/7525	11
WP4263	Pancreatic adenocarcinoma pathway	43/3223	82/5488	0.898910821314294	0.999496944584873	0.999496944584873	208/369/9459/572/598/673/842/595/1021/1147/1870/1956/1647/10912/3551/8517/3716/5604/5605/5599/4790/5037/5290/5293/5295/5296/8503/5337/5580/5880/10928/5970/54101/6198/4088/6772/6774/7039/7040/7043/7074/7157/7422	43
WP3303	RAC1/PAK1/p38/MMP2 pathway	33/3223	64/5488	0.902375683091299	0.999496944584873	0.999496944584873	9068/572/842/1147/1499/1956/1978/2335/2308/2885/3265/3551/8517/5600/6300/5603/5599/4313/4609/4690/4790/4792/4843/5290/5295/5970/6774/6776/6777/3925/7010/7157/10413	33
WP2870	Extracellular vesicle-mediated signaling in recipient cells	13/3223	27/5488	0.904937596368533	0.999496944584873	0.999496944584873	8312/1499/1956/3265/4240/23533/8842/4088/7039/7040/7043/7049/7474	13
WP5117	Cohesin complex - Cornelia de Lange syndrome	14/3223	29/5488	0.908249583023553	0.999496944584873	0.999496944584873	9212/157570/9700/23383/23244/5516/5526/5527/5528/5885/9985/8243/10735/10734	14
WP107	Translation factors	23/3223	46/5488	0.911941075567815	0.999496944584873	0.999496944584873	1915/1933/1936/1938/29904/1964/9086/9451/1967/8890/8893/8663/8664/3646/8665/8666/8667/1975/1978/1981/8672/23708/26986	23
WP4155	Endometrial cancer	30/3223	59/5488	0.913767169950624	0.999496944584873	0.999496944584873	208/369/8312/8313/572/673/842/595/1495/1499/1956/2260/2263/2353/1647/10912/2885/3265/51176/5604/5605/4609/5290/5293/5295/5296/8503/5728/6932/7157	30
WP244	Alpha 6 beta 4 signaling pathway	16/3223	33/5488	0.914703868617969	0.999496944584873	0.999496944584873	1978/2549/2885/3265/3667/8660/3655/3908/3911/3912/3915/3918/5295/5296/5580/6464	16
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	16/3223	33/5488	0.914703868617969	0.999496944584873	0.999496944584873	3480/3667/51528/84557/79109/4790/5294/5337/10891/5564/5728/253260/6198/57521/4088/7132	16
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	17/3223	35/5488	0.917817521229774	0.999496944584873	0.999496944584873	405/597/598/664/1906/3098/3486/3939/4843/5160/5366/6566/6513/7039/7043/7157/7422	17
WP3879	4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression	8/3223	18/5488	0.928471472914337	0.999496944584873	0.999496944584873	1978/5604/5605/5608/4217/2872/55872/7248	8
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	8/3223	18/5488	0.928471472914337	0.999496944584873	0.999496944584873	369/673/9146/3187/3265/22808/5869/6237	8
WP368	Mitochondrial long chain fatty acid beta-oxidation	7/3223	16/5488	0.928498882879625	0.999496944584873	0.999496944584873	37/2181/1374/3033/3030/6342/788	7
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	7/3223	16/5488	0.928498882879625	0.999496944584873	0.999496944584873	1964/8663/8664/3646/8665/8666/8667	7
WP366	TGF-beta signaling pathway	67/3223	127/5488	0.929164539920027	0.999496944584873	0.999496944584873	467/8312/595/1030/1387/1601/55802/1874/1875/163126/2033/2113/2335/2353/2354/50943/2885/3065/9146/3690/3725/3727/1316/3985/5604/5605/5608/6885/11184/5599/4205/4208/4312/4321/4609/9972/5295/5296/64219/5494/5934/54778/6093/860/6464/25942/6498/6500/4088/57154/64750/79753/57559/11171/7027/7040/7049/7050/7057/3371/7157/10131/7329/51377/10413/6935/9765	67
WP4753	Nucleotide excision repair	21/3223	43/5488	0.929366621773559	0.999496944584873	0.999496944584873	902/1022/1069/8450/2067/2068/2071/2072/2966/728340/3978/5424/5425/57804/5426/5427/5981/5983/5984/6117/6118	21
WP272	Blood clotting cascade	6/3223	14/5488	0.929368447889555	0.999496944584873	0.999496944584873	2161/8263/3816/5327/5328/5345	6
WP4483	Relationship between inflammation, COX-2 and EGFR	10/3223	22/5488	0.9300147056849	0.999496944584873	0.999496944584873	208/673/1956/3265/4312/5290/5293/5294/5732/5733	10
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	10/3223	22/5488	0.9300147056849	0.999496944584873	0.999496944584873	246/240/10800/1800/2358/2687/1241/5465/5467/22949	10
WP241	One-carbon metabolism	11/3223	24/5488	0.931289816686058	0.999496944584873	0.999496944584873	23382/10840/471/55349/1786/1788/2346/4522/4548/6470/6948	11
WP3965	Lipid metabolism pathway	11/3223	24/5488	0.931289816686058	0.999496944584873	0.999496944584873	31/47/55902/208/2194/5160/5563/5564/5567/51422/5573	11
WP4724	Omega-9 fatty acid synthesis	5/3223	12/5488	0.93145655543257	0.999496944584873	0.999496944584873	2181/79071/9415/2194/6319	5
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	23/3223	47/5488	0.934575573032809	0.999496944584873	0.999496944584873	8312/1051/1052/1387/1499/1513/3065/23463/51176/4128/4129/4673/4851/5468/860/4088/6696/6895/6932/7040/7088/7112/4982	23
WP1425	Bone morphogenic protein (BMP) signaling and regulation	4/3223	10/5488	0.935346341154925	0.999496944584873	0.999496944584873	860/4091/57154/10140	4
WP2881	Estrogen receptor pathway	4/3223	10/5488	0.935346341154925	0.999496944584873	0.999496944584873	3725/5166/5465/6774	4
WP4949	16p11.2 proximal deletion syndrome	31/3223	62/5488	0.936564389207106	0.999496944584873	0.999496944584873	2186/283897/8030/11151/79153/8841/3486/283899/253980/3835/58508/8085/5608/4150/4478/4790/79447/143/22976/5468/5516/5528/5531/9989/5728/5966/6693/7157/7186/23025/83719	31
WP2873	Aryl hydrocarbon receptor pathway	15/3223	32/5488	0.937896740721081	0.999496944584873	0.999496944584873	57491/9049/218/405/10486/11140/1956/2033/3553/3725/3727/4257/26509/7040/7124	15
WP2064	Neural crest differentiation	28/3223	57/5488	0.946023564532713	0.999496944584873	0.999496944584873	8312/8313/655/1280/1488/1499/54567/1855/1856/1857/2113/2260/2263/7976/3065/8841/10014/51564/9734/3198/4609/4790/4791/4851/4853/5376/6660/6925	28
WP5036	Angiotensin II receptor type 1 pathway	10/3223	23/5488	0.954431249557827	0.999496944584873	0.999496944584873	59272/59/2161/3590/3727/5608/80310/6237/4088/7040	10
WP2509	Nanoparticle triggered autophagic cell death	9/3223	21/5488	0.954552109861548	0.999496944584873	0.999496944584873	55626/83734/64422/596/84557/7248/7249/8408/7405	9
WP2643	Nanoparticle-mediated activation of receptor signaling	12/3223	27/5488	0.955039422194192	0.999496944584873	0.999496944584873	1956/2335/2885/3265/3672/5604/5605/5600/6300/5603/5599/5293	12
WP1591	Heart development	13/3223	29/5488	0.955641497330579	0.999496944584873	0.999496944584873	8553/1499/2627/23462/4208/4772/4773/4851/6469/6722/6909/7422/7423	13
WP179	Cell cycle	58/3223	113/5488	0.955745814902315	0.999496944584873	0.999496944584873	25847/29882/29945/51433/51434/472/545/9184/595/896/9134/902/8556/8555/994/995/990/1017/1021/1022/1028/1030/1031/1032/1111/10926/1870/1874/1875/2033/9700/1647/10912/3065/8379/10459/4171/4172/4174/4609/23595/9088/5885/5934/2810/6500/4088/8243/10735/7027/7029/7040/7043/7157/7465/7531/10971/7709	58
WP325	Triacylglyceride synthesis	7/3223	17/5488	0.95612307868517	0.999496944584873	0.999496944584873	10554/56894/56895/8694/2710/2819/4023	7
WP111	Electron transport chain: OXPHOS system in mitochondria	34/3223	69/5488	0.957145553521868	0.999496944584873	0.999496944584873	10063/9377/1337/1340/1347/1349/1350/4694/4698/4700/4701/4706/4708/4709/4710/4711/4712/4719/4724/4723/6341/6389/6390/6391/6392/9016/9481/292/293/6834/7351/7385/7386/27089	34
WP4932	7q11.23 copy number variation syndrome	41/3223	82/5488	0.957412082255707	0.999496944584873	0.999496944584873	31/91647/9031/23476/695/1028/23332/23122/9076/1364/7461/1499/1738/83939/9451/2006/355/10516/2597/2885/8841/3306/7462/3984/4609/4641/23636/4967/5592/8878/6804/26608/7324/9246/29914/8408/7391/6844/137492/79720/55048	41
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	6/3223	15/5488	0.957866228125185	0.999496944584873	0.999496944584873	2335/860/4088/7040/3371/7431	6
WP4558	Overview of interferons-mediated signaling pathway	6/3223	15/5488	0.957866228125185	0.999496944584873	0.999496944584873	3460/3716/5290/5295/6772/7297	6
WP698	Glucuronidation	5/3223	13/5488	0.96053180669912	0.999496944584873	0.999496944584873	3098/5236/5238/5239/7360	5
WP673	ErbB signaling pathway	38/3223	77/5488	0.963236078339078	0.999496944584873	0.999496944584873	208/369/572/673/685/867/868/595/1956/1978/2069/2308/2549/2885/1839/3265/3725/5604/5605/5609/5599/4609/4690/8440/5290/5293/5295/5296/8503/5335/5336/5579/6198/6464/6776/6777/7039/7157	38
WP4747	Netrin-UNC5B signaling pathway	21/3223	45/5488	0.963302235100586	0.999496944584873	0.999496944584873	116986/23365/836/2534/3552/3635/3725/3791/5604/5605/9423/59277/5290/5499/2185/6018/7124/7157/219699/7412/10413	21
WP229	Irinotecan pathway	4/3223	11/5488	0.964430786754021	0.999496944584873	0.999496944584873	4363/590/8824/1576	4
WP4723	Omega-3 / omega-6 fatty acid synthesis	4/3223	11/5488	0.964430786754021	0.999496944584873	0.999496944584873	2181/9415/5321/8398	4
WP138	Androgen receptor signaling pathway	40/3223	81/5488	0.965941812805473	0.999496944584873	0.999496944584873	573/90427/811/595/1385/1387/1499/1616/1956/2033/2274/2308/3065/3725/3985/8202/8031/9612/23598/10401/51588/5295/5296/5052/29893/5728/5883/5970/6047/6093/860/25942/23411/4088/6774/10273/7050/7329/57178/24149	40
WP306	Focal adhesion	90/3223	173/5488	0.970618214047983	0.999496944584873	0.999496944584873	71/208/394/572/596/329/330/640/673/824/595/896/1280/1282/1284/1286/1288/1290/1499/1793/1956/2317/2321/2335/2534/2885/3265/3480/3672/3676/3655/3679/8516/3680/3685/3690/3694/3725/3791/3908/3910/3911/3912/3915/3918/10319/5604/5599/10627/4636/10398/55742/64098/5155/56034/80310/5156/5290/5293/5295/5296/8503/23396/5499/4659/4660/54776/5579/5728/5880/5906/5908/2889/5923/6093/6464/6696/7057/7058/7059/3371/10188/7148/7294/7408/7409/10451/7414/7422/7423	90
WP2875	Constitutive androstane receptor pathway	10/3223	24/5488	0.970960844466233	0.999496944584873	0.999496944584873	5243/8714/1557/1576/7266/2308/10891/8243/6817/6822	10
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	9/3223	22/5488	0.971539543522305	0.999496944584873	0.999496944584873	2022/2201/4052/4053/5599/860/6464/4088/7049	9
WP2038	Microtubule cytoskeleton regulation	19/3223	42/5488	0.972936136787698	0.999496944584873	0.999496944584873	9212/814/23332/1855/2048/2776/3984/4131/9261/2011/5290/5728/6093/6774/3925/57551/7074/11076/7204	19
WP5066	FOXA2 pathway	7/3223	18/5488	0.973719555084791	0.999496944584873	0.999496944584873	8714/31/2194/2308/3667/8660/133522	7
WP4875	Disruption of postsynaptic signaling by CNV	6/3223	16/5488	0.97548663527252	0.999496944584873	0.999496944584873	2332/9379/9369/6804/8831/7082	6
WP2446	Retinoblastoma gene in cancer	42/3223	86/5488	0.975904601578342	0.999496944584873	0.999496944584873	54443/580/8030/595/896/9134/994/1017/1021/1111/1633/1786/1870/3065/6596/3146/3148/5603/4172/2956/4609/4863/5426/5427/5877/5928/5931/5983/5984/6117/6118/6240/8819/25942/6595/8243/3925/7027/7029/7157/7465/79027	42
WP691	Tamoxifen metabolism	5/3223	14/5488	0.977844783815545	0.999496944584873	0.999496944584873	1557/1565/1576/6817/6822	5
WP4396	Nonalcoholic fatty liver disease	68/3223	135/5488	0.980942955020293	0.999496944584873	0.999496944584873	79602/208/27113/836/9377/1337/1340/1347/1349/1350/54205/9451/355/356/3551/3552/3553/3569/3570/3667/8660/3725/4217/5599/6945/22877/4694/126328/4698/4700/4701/4706/54539/4708/4709/4710/4711/4712/4719/4724/4723/4790/10062/9971/5290/5293/5295/5296/8503/5465/5563/5564/51422/5970/6389/6390/6391/6392/9021/7040/7124/7132/7186/7385/7386/27089/7412/7494	68
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	32/3223	68/5488	0.981042792820321	0.999496944584873	0.999496944584873	208/369/8312/8313/572/27113/596/673/836/842/595/1499/54205/55770/2353/1647/10912/3725/51176/5604/5599/2956/4609/9423/5366/5880/5966/4088/6932/7040/7043/7157	32
WP466	DNA replication	18/3223	41/5488	0.981159944181537	0.999496944584873	0.999496944584873	990/1017/10926/4171/4172/4174/23595/5424/5425/57804/5426/5427/5981/5983/5984/6117/6118/7311	18
WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	19/3223	43/5488	0.981405707063165	0.999496944584873	0.999496944584873	31/83734/64422/23400/80067/79152/2512/54676/84557/4204/80025/8398/57521/6342/6794/7248/7249/8408/26100	19
WP5121	Sphingolipid metabolism in senescence	10/3223	25/5488	0.981856340260909	0.999496944584873	0.999496944584873	1017/29956/79603/2629/2531/5579/1901/166929/81537/8877	10
WP4657	22q11.2 copy number variation syndrome	39/3223	82/5488	0.984881144931384	0.999496944584873	0.999496944584873	59/150209/8854/406/421/25842/596/128977/23468/9076/8452/56603/9681/1956/2260/2263/2746/2811/8841/84861/10892/51586/4942/5297/5430/5625/6097/57142/6469/6576/6517/6721/6722/80764/7157/27037/10587/7514/29801	39
WP3874	Canonical and non-canonical TGF-B signaling	6/3223	17/5488	0.986048575229257	0.999496944584873	0.999496944584873	649/26585/84171/5599/4088/7040	6
WP2035	Follicle stimulating hormone (FSH) signaling pathway	7/3223	20/5488	0.991144493655051	0.999496944584873	0.999496944584873	1385/1978/2308/2870/6194/6198/7249	7
WP2876	Pregnane X receptor pathway	10/3223	27/5488	0.993283466262634	0.999496944584873	0.999496944584873	5243/8714/1557/1576/1551/7266/2308/8202/10891/6822	10
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	8/3223	23/5488	0.99434507802388	0.999496944584873	0.999496944584873	231/5321/8398/5467/5729/11251/5730/22949	8
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	8/3223	23/5488	0.99434507802388	0.999496944584873	0.999496944584873	1267/2254/5604/5605/5600/6300/5603/6772	8
WP702	Metapathway biotransformation Phase I and II	49/3223	105/5488	0.995525276028188	0.999496944584873	0.999496944584873	10327/231/57016/1645/1646/8644/22977/9486/50515/113189/9435/56603/1593/1557/1565/1573/29785/113612/51302/1576/1551/4051/285440/260293/2052/2053/2329/64090/79690/2878/2936/2941/2948/9446/2950/9653/9957/11185/8514/4257/4258/79829/80218/55226/57106/26151/6817/6819/6822	49
WP4923	Autophagy	10/3223	28/5488	0.996009906086427	0.999496944584873	0.999496944584873	55626/64422/81631/5563/5564/51422/57521/8408/7405/26100	10
WP697	Estrogen metabolism	3/3223	12/5488	0.996326357920443	0.999496944584873	0.999496944584873	414/1576/6817	3
WP411	mRNA processing	57/3223	122/5488	0.997401583880055	0.999496944584873	0.999496944584873	10421/10658/10659/11129/1195/1196/1198/57396/10898/1477/23283/1653/1665/9785/22826/3178/3183/3187/3188/3191/56339/11051/10482/8106/5430/5496/9129/10594/58155/84991/9584/10181/27316/8732/8731/10921/8175/10946/6433/8243/6625/6633/140890/6729/6733/6426/6429/6430/6431/8683/57794/10147/6829/10972/7307/11338/4904	57
WP623	Oxidative phosphorylation	13/3223	36/5488	0.998207408288298	0.999496944584873	0.999496944584873	3002/126328/4698/4700/4701/4706/4708/4710/4711/4712/4719/4724/4723	13
WP4963	p53 transcriptional gene network	33/3223	78/5488	0.998873791447378	0.999496944584873	0.999496944584873	136/317/27113/7832/900/995/1017/54541/144455/2176/355/356/1647/3663/4255/4851/5366/5429/5563/5564/51422/5728/57521/50484/2810/6513/7057/7124/8793/94241/7249/8408/64393	33
WP2359	Parkin-ubiquitin proteasomal system pathway	23/3223	58/5488	0.998938768106575	0.999496944584873	0.999496944584873	8573/834/55294/3303/3305/3306/3308/3309/3313/5709/5711/6478/10273/7277/79861/203068/7280/347733/10381/7326/7327/118424/9246	23
WP4863	Host-pathogen interaction of human coronaviruses - autophagy	5/3223	19/5488	0.999067649311626	0.999496944584873	0.999496944584873	83734/89849/64422/84557/8408	5
WP183	Proteasome degradation	21/3223	55/5488	0.999358994352596	0.999496944584873	0.999496944584873	3105/3135/4734/5683/5684/5685/5686/5687/5689/5699/5690/5696/5698/5709/5711/5720/5721/6184/6185/7321/7322	21
WP2267	Synaptic vesicle pathway	11/3223	34/5488	0.999496944584873	0.999496944584873	0.999496944584873	163/2055/1759/1785/26052/6571/81539/6804/6855/23025/6844	11
